date
Note that the current default version of R is 3.6.1.
Loading required package: network
network: Classes for Relational Data
Version 1.15 created on 2019-04-01.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
                    Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Martina Morris, University of Washington
                    Skye Bender-deMoll, University of Washington
 For citation information, type citation("network").
 Type help("network-package") to get started.


networkDynamic: version 0.10.0, created on 2019-04-04
Copyright (c) 2019, Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Skye Bender-deMoll, University of Washington
                    with contributions from
                    Zack Almquist, University of California -- Irvine
                    David R. Hunter, Penn State University
                    Li Wang
                    Kirk Li, University of Washington
                    Steven M. Goodreau, University of Washington
                    Jeffrey Horner
                    Martina Morris, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("networkDynamic").

Loading required package: statnet.common

Attaching package: ‘statnet.common’

The following object is masked from ‘package:base’:

    order

sna: Tools for Social Network Analysis
Version 2.4 created on 2016-07-23.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
 For citation information, type citation("sna").
 Type help(package="sna") to get started.


ergm: version 3.10.4, created on 2019-06-10
Copyright (c) 2019, Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Carter T. Butts, University of California -- Irvine
                    Steven M. Goodreau, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Martina Morris, University of Washington
                    with contributions from
                    Li Wang
                    Kirk Li, University of Washington
                    Skye Bender-deMoll, University of Washington
                    Chad Klumb
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("ergm").

NOTE: Versions before 3.6.1 had a bug in the implementation of the bd()
constriant which distorted the sampled distribution somewhat. In
addition, Sampson's Monks datasets had mislabeled vertices. See the
NEWS and the documentation for more details.

NOTE: Some common term arguments pertaining to vertex attribute and
level selection have changed in 3.10.0. See terms help for more
details. Use ‘options(ergm.term=list(version="3.9.4"))’ to use old
behavior.


tergm: version 3.6.1, created on 2019-06-12
Copyright (c) 2019, Pavel N. Krivitsky, University of Wollongong
                    Mark S. Handcock, University of California -- Los Angeles
                    with contributions from
                    David R. Hunter, Penn State University
                    Steven M. Goodreau, University of Washington
                    Martina Morris, University of Washington
                    Nicole Bohme Carnegie, New York University
                    Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Skye Bender-deMoll
                    Li Wang
                    Kirk Li, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("tergm").

Starting maximum pseudolikelihood estimation (MPLE):
Evaluating the predictor and response matrix.
Maximizing the pseudolikelihood.
Finished MPLE.
Starting Monte Carlo maximum likelihood estimation (MCMLE):
Iteration 1 of at most 500:
Optimizing with step length 0.388733985340586.
The log-likelihood improved by 2.99.
Iteration 2 of at most 500:
Optimizing with step length 0.905323647251503.
The log-likelihood improved by 3.485.
Iteration 3 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 0.2318.
Step length converged once. Increasing MCMC sample size.
Iteration 4 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 0.4137.
Step length converged twice. Stopping.
Finished MCMLE.
This model was fit using MCMC.  To examine model diagnostics and check
for degeneracy, use the mcmc.diagnostics() function.
 degree1  degree2  degree3  degree4  degree5  degree6  degree7  degree8 
      20     1276     1071      811      324      361      349      298 
 degree9 degree10 degree11 degree12 degree13 degree14 degree15 degree18 
     197      133       75       38       30       10        6        1 
1 
disease_progression 
H-positive risk:  933 855 125 895 403 119 855 464 117 49 114 71 
H-negative risk:  855 933 855 895 464 403 119 125 114 117 71 49 
New BC onsets:  1
BC status:  4999 1 
BC subtype:  4999 1 

clinical_engagement 
diagnosis 
demography 
57 new agents 
2 
disease_progression 
H-positive risk:  937 859 126 896 398 118 856 459 119 49 113 70 
H-negative risk:  859 937 856 896 459 398 118 126 113 119 70 49 
New BC onsets:  6
BC status:  4994 6 
BC subtype:  4994 5 1 

clinical_engagement 
diagnosis 
demography 
58 new agents 
3 
disease_progression 
H-positive risk:  946 860 125 896 389 115 859 455 120 48 115 72 
H-negative risk:  860 946 859 896 455 389 115 125 115 120 72 48 
New BC onsets:  9
BC status:  4991 9 
BC subtype:  4991 7 2 

clinical_engagement 
diagnosis 
demography 
53 new agents 
4 
disease_progression 
H-positive risk:  952 864 127 900 378 116 862 448 120 47 115 71 
H-negative risk:  864 952 862 900 448 378 116 127 115 120 71 47 
New BC onsets:  10
BC status:  4990 10 
BC subtype:  4990 8 2 

clinical_engagement 
diagnosis 
demography 
73 new agents 
5 
disease_progression 
H-positive risk:  959 874 127 896 370 117 871 435 120 47 115 69 
H-negative risk:  874 959 871 896 435 370 117 127 115 120 69 47 
New BC onsets:  13
BC status:  4987 13 
BC subtype:  4987 10 3 

clinical_engagement 
diagnosis 
demography 
50 new agents 
6 
disease_progression 
H-positive risk:  960 876 127 900 366 115 875 432 120 45 115 69 
H-negative risk:  876 960 875 900 432 366 115 127 115 120 69 45 
New BC onsets:  14
BC status:  4986 14 
BC subtype:  4986 10 4 

clinical_engagement 
diagnosis 
demography 
56 new agents 
7 
disease_progression 
H-positive risk:  964 883 126 897 364 117 877 423 121 44 115 69 
H-negative risk:  883 964 877 897 423 364 117 126 115 121 69 44 
New BC onsets:  16
BC status:  4984 16 
BC subtype:  4984 12 4 

clinical_engagement 
diagnosis 
demography 
56 new agents 
8 
disease_progression 
H-positive risk:  969 890 126 895 360 118 869 421 121 46 115 70 
H-negative risk:  890 969 869 895 421 360 118 126 115 121 70 46 
New BC onsets:  20
BC status:  4980 20 
BC subtype:  4980 15 5 

clinical_engagement 
diagnosis 
demography 
41 new agents 
9 
disease_progression 
H-positive risk:  970 895 127 891 358 117 871 422 120 46 114 69 
H-negative risk:  895 970 871 891 422 358 117 127 114 120 69 46 
New BC onsets:  24
BC status:  4976 24 
BC subtype:  4976 19 5 

clinical_engagement 
diagnosis 
demography 
65 new agents 
10 
disease_progression 
H-positive risk:  973 898 129 889 360 120 872 419 118 44 112 66 
H-negative risk:  898 973 872 889 419 360 120 129 112 118 66 44 
New BC onsets:  29
BC status:  4971 29 
BC subtype:  4971 24 5 

clinical_engagement 
diagnosis 
demography 
58 new agents 
11 
disease_progression 
H-positive risk:  978 908 128 883 358 122 869 421 115 42 112 64 
H-negative risk:  908 978 869 883 421 358 122 128 112 115 64 42 
New BC onsets:  30
BC status:  4970 30 
BC subtype:  4970 23 7 

clinical_engagement 
diagnosis 
demography 
56 new agents 
12 
disease_progression 
H-positive risk:  976 913 129 876 364 123 871 412 116 42 114 64 
H-negative risk:  913 976 871 876 412 364 123 129 114 116 64 42 
New BC onsets:  34
BC status:  4966 34 
BC subtype:  4966 27 7 

clinical_engagement 
diagnosis 
demography 
53 new agents 
13 
disease_progression 
H-positive risk:  889 832 120 963 362 114 961 403 127 43 122 64 
H-negative risk:  832 889 961 963 403 362 114 120 122 127 64 43 
New BC onsets:  35
BC status:  4965 35 
BC subtype:  4965 28 7 

clinical_engagement 
diagnosis 
demography 
206 new agents 
14 
disease_progression 
H-positive risk:  919 857 128 917 371 116 914 429 120 49 112 68 
H-negative risk:  857 919 914 917 429 371 116 128 112 120 68 49 
New BC onsets:  40
BC status:  4960 40 
BC subtype:  4960 33 7 

clinical_engagement 
diagnosis 
demography 
75 new agents 
15 
disease_progression 
H-positive risk:  918 858 130 918 369 117 916 424 121 48 113 68 
H-negative risk:  858 918 916 918 424 369 117 130 113 121 68 48 
New BC onsets:  43
BC status:  4957 43 
BC subtype:  4957 36 7 

clinical_engagement 
diagnosis 
demography 
51 new agents 
16 
disease_progression 
H-positive risk:  919 864 130 921 364 118 916 424 119 45 111 69 
H-negative risk:  864 919 916 921 424 364 118 130 111 119 69 45 
New BC onsets:  46
BC status:  4954 46 
BC subtype:  4954 38 8 

clinical_engagement 
diagnosis 
demography 
56 new agents 
17 
disease_progression 
H-positive risk:  924 861 133 926 360 118 917 420 118 45 110 68 
H-negative risk:  861 924 917 926 420 360 118 133 110 118 68 45 
New BC onsets:  47
BC status:  4953 47 
BC subtype:  4953 39 8 

clinical_engagement 
diagnosis 
demography 
68 new agents 
18 
disease_progression 
H-positive risk:  929 864 133 918 356 119 924 415 118 45 113 66 
H-negative risk:  864 929 924 918 415 356 119 133 113 118 66 45 
New BC onsets:  49
BC status:  4951 49 
BC subtype:  4951 38 11 

clinical_engagement 
diagnosis 
demography 
60 new agents 
19 
disease_progression 
H-positive risk:  934 860 134 915 359 120 922 415 120 45 111 65 
H-negative risk:  860 934 922 915 415 359 120 134 111 120 65 45 
New BC onsets:  55
BC status:  4945 55 
BC subtype:  4945 43 12 

clinical_engagement 
diagnosis 
demography 
58 new agents 
20 
disease_progression 
H-positive risk:  938 866 132 917 353 121 916 416 119 47 111 64 
H-negative risk:  866 938 916 917 416 353 121 132 111 119 64 47 
New BC onsets:  54
BC status:  4946 54 
BC subtype:  4946 44 10 

clinical_engagement 
diagnosis 
demography 
63 new agents 
21 
disease_progression 
H-positive risk:  940 869 134 919 351 123 910 414 120 47 111 62 
H-negative risk:  869 940 910 919 414 351 123 134 111 120 62 47 
New BC onsets:  61
BC status:  4939 61 
BC subtype:  4939 47 14 

clinical_engagement 
diagnosis 
demography 
65 new agents 
22 
disease_progression 
H-positive risk:  939 878 136 912 351 122 910 414 120 48 111 59 
H-negative risk:  878 939 910 912 414 351 122 136 111 120 59 48 
New BC onsets:  61
BC status:  4939 61 
BC subtype:  4939 47 14 

clinical_engagement 
diagnosis 
demography 
59 new agents 
23 
disease_progression 
H-positive risk:  943 884 136 909 343 124 912 413 123 48 109 56 
H-negative risk:  884 943 912 909 413 343 124 136 109 123 56 48 
New BC onsets:  62
BC status:  4938 62 
BC subtype:  4938 48 14 

clinical_engagement 
diagnosis 
demography 
60 new agents 
24 
disease_progression 
H-positive risk:  953 885 134 910 337 124 916 408 124 49 106 54 
H-negative risk:  885 953 916 910 408 337 124 134 106 124 54 49 
New BC onsets:  64
BC status:  4936 64 
BC subtype:  4936 49 15 

clinical_engagement 
diagnosis 
demography 
59 new agents 
25 
disease_progression 
H-positive risk:  892 812 124 979 341 112 980 405 135 49 119 52 
H-negative risk:  812 892 980 979 405 341 112 124 119 135 52 49 
New BC onsets:  65
BC status:  4935 65 
BC subtype:  4935 49 16 

clinical_engagement 
diagnosis 
demography 
193 new agents 
26 
disease_progression 
H-positive risk:  915 839 128 937 364 110 941 413 130 54 118 51 
H-negative risk:  839 915 941 937 413 364 110 128 118 130 51 54 
New BC onsets:  71
BC status:  4929 71 
BC subtype:  4929 54 17 

clinical_engagement 
diagnosis 
demography 
88 new agents 
27 
disease_progression 
H-positive risk:  927 840 129 941 364 108 927 414 130 53 116 51 
H-negative risk:  840 927 927 941 414 364 108 129 116 130 51 53 
New BC onsets:  71
BC status:  4929 71 
BC subtype:  4929 54 17 

clinical_engagement 
diagnosis 
demography 
60 new agents 
28 
disease_progression 
H-positive risk:  929 841 129 943 357 109 931 410 130 55 116 50 
H-negative risk:  841 929 931 943 410 357 109 129 116 130 50 55 
New BC onsets:  73
BC status:  4927 73 
BC subtype:  4927 56 17 

clinical_engagement 
diagnosis 
demography 
63 new agents 
29 
disease_progression 
H-positive risk:  926 841 128 951 352 108 938 404 127 56 119 50 
H-negative risk:  841 926 938 951 404 352 108 128 119 127 50 56 
New BC onsets:  73
BC status:  4927 73 
BC subtype:  4927 56 17 

clinical_engagement 
diagnosis 
demography 
63 new agents 
30 
disease_progression 
H-positive risk:  930 842 125 952 354 107 938 401 128 54 119 50 
H-negative risk:  842 930 938 952 401 354 107 125 119 128 50 54 
New BC onsets:  74
BC status:  4926 74 
BC subtype:  4926 56 18 

clinical_engagement 
diagnosis 
demography 
53 new agents 
31 
disease_progression 
H-positive risk:  933 837 125 952 351 107 940 406 124 55 121 49 
H-negative risk:  837 933 940 952 406 351 107 125 121 124 49 55 
New BC onsets:  74
BC status:  4926 74 
BC subtype:  4926 57 17 

clinical_engagement 
diagnosis 
demography 
59 new agents 
32 
disease_progression 
H-positive risk:  937 833 125 957 349 108 933 406 127 55 121 49 
H-negative risk:  833 937 933 957 406 349 108 125 121 127 49 55 
New BC onsets:  76
BC status:  4924 76 
BC subtype:  4924 59 17 

clinical_engagement 
diagnosis 
demography 
65 new agents 
33 
disease_progression 
H-positive risk:  933 838 126 948 348 107 937 408 129 53 123 50 
H-negative risk:  838 933 937 948 408 348 107 126 123 129 50 53 
New BC onsets:  78
BC status:  4922 78 
BC subtype:  4922 61 17 

clinical_engagement 
diagnosis 
demography 
70 new agents 
34 
disease_progression 
H-positive risk:  940 847 128 938 353 106 943 394 130 52 120 49 
H-negative risk:  847 940 943 938 394 353 106 128 120 130 49 52 
New BC onsets:  78
BC status:  4922 78 
BC subtype:  4922 61 17 

clinical_engagement 
diagnosis 
demography 
67 new agents 
35 
disease_progression 
H-positive risk:  945 847 128 932 356 106 950 389 130 51 119 47 
H-negative risk:  847 945 950 932 389 356 106 128 119 130 47 51 
New BC onsets:  81
BC status:  4919 81 
BC subtype:  4919 64 17 

clinical_engagement 
diagnosis 
demography 
48 new agents 
36 
disease_progression 
H-positive risk:  947 848 130 936 355 108 942 389 131 49 119 46 
H-negative risk:  848 947 942 936 389 355 108 130 119 131 46 49 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 64 18 

clinical_engagement 
diagnosis 
demography 
68 new agents 
37 
disease_progression 
H-positive risk:  881 776 120 1000 357 100 1014 384 143 50 130 45 
H-negative risk:  776 881 1014 1000 384 357 100 120 130 143 45 50 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 67 20 

clinical_engagement 
diagnosis 
demography 
133 new agents 
38 
disease_progression 
H-positive risk:  890 787 121 974 382 104 967 407 132 61 124 51 
H-negative risk:  787 890 967 974 407 382 104 121 124 132 51 61 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 68 19 

clinical_engagement 
diagnosis 
demography 
72 new agents 
39 
disease_progression 
H-positive risk:  890 789 123 972 388 105 959 412 131 58 123 50 
H-negative risk:  789 890 959 972 412 388 105 123 123 131 50 58 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 69 20 

clinical_engagement 
diagnosis 
demography 
72 new agents 
40 
disease_progression 
H-positive risk:  895 789 123 967 389 106 948 418 128 58 128 51 
H-negative risk:  789 895 948 967 418 389 106 123 128 128 51 58 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 69 19 

clinical_engagement 
diagnosis 
demography 
61 new agents 
41 
disease_progression 
H-positive risk:  893 793 123 965 388 106 949 416 127 58 129 53 
H-negative risk:  793 893 949 965 416 388 106 123 129 127 53 58 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 68 19 

clinical_engagement 
diagnosis 
demography 
73 new agents 
42 
disease_progression 
H-positive risk:  895 798 125 964 383 107 947 412 128 57 128 56 
H-negative risk:  798 895 947 964 412 383 107 125 128 128 56 57 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 72 19 

clinical_engagement 
diagnosis 
demography 
72 new agents 
43 
disease_progression 
H-positive risk:  898 807 128 963 378 108 940 411 127 57 129 54 
H-negative risk:  807 898 940 963 411 378 108 128 129 127 54 57 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 72 19 

clinical_engagement 
diagnosis 
demography 
55 new agents 
44 
disease_progression 
H-positive risk:  903 809 132 963 365 108 941 410 128 58 128 55 
H-negative risk:  809 903 941 963 410 365 108 132 128 128 55 58 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 73 19 

clinical_engagement 
diagnosis 
demography 
63 new agents 
45 
disease_progression 
H-positive risk:  906 814 131 963 365 105 944 406 127 59 128 52 
H-negative risk:  814 906 944 963 406 365 105 131 128 127 52 59 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 72 19 

clinical_engagement 
diagnosis 
demography 
73 new agents 
46 
disease_progression 
H-positive risk:  917 815 130 956 362 104 941 410 132 56 125 52 
H-negative risk:  815 917 941 956 410 362 104 130 125 132 52 56 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 75 19 

clinical_engagement 
diagnosis 
demography 
63 new agents 
47 
disease_progression 
H-positive risk:  922 821 134 956 354 106 932 410 129 58 126 52 
H-negative risk:  821 922 932 956 410 354 106 134 126 129 52 58 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 76 20 

clinical_engagement 
diagnosis 
demography 
65 new agents 
48 
disease_progression 
H-positive risk:  919 827 135 955 352 107 926 412 131 56 126 54 
H-negative risk:  827 919 926 955 412 352 107 135 126 131 54 56 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 77 19 

clinical_engagement 
diagnosis 
demography 
55 new agents 
49 
disease_progression 
H-positive risk:  865 776 130 1013 354 100 976 411 138 54 129 54 
H-negative risk:  776 865 976 1013 411 354 100 130 129 138 54 54 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 81 18 

clinical_engagement 
diagnosis 
demography 
152 new agents 
50 
disease_progression 
H-positive risk:  870 795 131 999 359 102 972 408 136 52 129 47 
H-negative risk:  795 870 972 999 408 359 102 131 129 136 47 52 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 84 18 

clinical_engagement 
diagnosis 
demography 
80 new agents 
51 
disease_progression 
H-positive risk:  872 803 132 991 358 103 980 398 134 52 130 47 
H-negative risk:  803 872 980 991 398 358 103 132 130 134 47 52 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 85 18 

clinical_engagement 
diagnosis 
demography 
70 new agents 
52 
disease_progression 
H-positive risk:  874 806 132 996 358 99 975 398 136 54 123 49 
H-negative risk:  806 874 975 996 398 358 99 132 123 136 49 54 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 85 17 

clinical_engagement 
diagnosis 
demography 
78 new agents 
53 
disease_progression 
H-positive risk:  884 814 131 995 361 98 966 391 134 56 122 48 
H-negative risk:  814 884 966 995 391 361 98 131 122 134 48 56 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 83 18 

clinical_engagement 
diagnosis 
demography 
63 new agents 
54 
disease_progression 
H-positive risk:  884 820 130 992 364 98 963 393 136 55 117 48 
H-negative risk:  820 884 963 992 393 364 98 130 117 136 48 55 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 86 18 

clinical_engagement 
diagnosis 
demography 
71 new agents 
55 
disease_progression 
H-positive risk:  882 825 131 993 363 100 971 387 132 53 116 47 
H-negative risk:  825 882 971 993 387 363 100 131 116 132 47 53 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 85 17 

clinical_engagement 
diagnosis 
demography 
74 new agents 
56 
disease_progression 
H-positive risk:  882 829 131 990 357 98 979 383 136 51 118 46 
H-negative risk:  829 882 979 990 383 357 98 131 118 136 46 51 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 86 17 

clinical_engagement 
diagnosis 
demography 
46 new agents 
57 
disease_progression 
H-positive risk:  883 827 131 997 354 98 977 381 136 53 116 47 
H-negative risk:  827 883 977 997 381 354 98 131 116 136 47 53 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 84 17 

clinical_engagement 
diagnosis 
demography 
57 new agents 
58 
disease_progression 
H-positive risk:  884 833 135 999 353 99 973 373 136 52 116 47 
H-negative risk:  833 884 973 999 373 353 99 135 116 136 47 52 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 83 16 

clinical_engagement 
diagnosis 
demography 
53 new agents 
59 
disease_progression 
H-positive risk:  893 832 137 994 347 100 974 372 134 53 117 47 
H-negative risk:  832 893 974 994 372 347 100 137 117 134 47 53 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 86 16 

clinical_engagement 
diagnosis 
demography 
66 new agents 
60 
disease_progression 
H-positive risk:  903 832 137 996 343 102 970 367 130 55 117 48 
H-negative risk:  832 903 970 996 367 343 102 137 117 130 48 55 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 85 17 

clinical_engagement 
diagnosis 
demography 
51 new agents 
61 
disease_progression 
H-positive risk:  843 793 125 1034 336 92 1033 363 145 55 133 48 
H-negative risk:  793 843 1033 1034 363 336 92 125 133 145 48 55 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 85 17 

clinical_engagement 
diagnosis 
demography 
127 new agents 
62 
disease_progression 
H-positive risk:  850 799 123 1008 352 92 1012 382 144 56 126 56 
H-negative risk:  799 850 1012 1008 382 352 92 123 126 144 56 56 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 89 18 

clinical_engagement 
diagnosis 
demography 
74 new agents 
63 
disease_progression 
H-positive risk:  852 804 126 1003 347 95 1010 382 141 56 126 58 
H-negative risk:  804 852 1010 1003 382 347 95 126 126 141 58 56 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 88 17 

clinical_engagement 
diagnosis 
demography 
89 new agents 
64 
disease_progression 
H-positive risk:  851 805 125 991 346 97 1018 384 144 56 125 58 
H-negative risk:  805 851 1018 991 384 346 97 125 125 144 58 56 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 89 16 

clinical_engagement 
diagnosis 
demography 
69 new agents 
65 
disease_progression 
H-positive risk:  857 801 126 989 347 98 1025 378 142 56 122 59 
H-negative risk:  801 857 1025 989 378 347 98 126 122 142 59 56 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 91 18 

clinical_engagement 
diagnosis 
demography 
67 new agents 
66 
disease_progression 
H-positive risk:  856 800 126 983 351 99 1029 380 141 56 120 59 
H-negative risk:  800 856 1029 983 380 351 99 126 120 141 59 56 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 89 18 

clinical_engagement 
diagnosis 
demography 
68 new agents 
67 
disease_progression 
H-positive risk:  864 802 130 981 344 101 1027 376 141 55 119 60 
H-negative risk:  802 864 1027 981 376 344 101 130 119 141 60 55 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 88 20 

clinical_engagement 
diagnosis 
demography 
77 new agents 
68 
disease_progression 
H-positive risk:  874 801 130 984 339 101 1025 368 145 53 120 60 
H-negative risk:  801 874 1025 984 368 339 101 130 120 145 60 53 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 87 22 

clinical_engagement 
diagnosis 
demography 
71 new agents 
69 
disease_progression 
H-positive risk:  872 805 133 986 334 101 1030 359 148 56 116 60 
H-negative risk:  805 872 1030 986 359 334 101 133 116 148 60 56 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 92 21 

clinical_engagement 
diagnosis 
demography 
68 new agents 
70 
disease_progression 
H-positive risk:  869 806 131 987 335 103 1037 352 149 52 119 60 
H-negative risk:  806 869 1037 987 352 335 103 131 119 149 60 52 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 89 22 

clinical_engagement 
diagnosis 
demography 
62 new agents 
71 
disease_progression 
H-positive risk:  866 808 130 987 331 106 1037 354 150 51 120 60 
H-negative risk:  808 866 1037 987 354 331 106 130 120 150 60 51 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 90 22 

clinical_engagement 
diagnosis 
demography 
79 new agents 
72 
disease_progression 
H-positive risk:  873 813 133 989 328 104 1031 349 148 51 118 63 
H-negative risk:  813 873 1031 989 349 328 104 133 118 148 63 51 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 92 22 

clinical_engagement 
diagnosis 
demography 
59 new agents 
73 
disease_progression 
H-positive risk:  808 762 124 1043 325 102 1104 344 151 52 125 60 
H-negative risk:  762 808 1104 1043 344 325 102 124 125 151 60 52 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 89 22 

clinical_engagement 
diagnosis 
demography 
127 new agents 
74 
disease_progression 
H-positive risk:  812 769 123 1017 336 103 1090 361 145 57 121 66 
H-negative risk:  769 812 1090 1017 361 336 103 123 121 145 66 57 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 87 22 

clinical_engagement 
diagnosis 
demography 
87 new agents 
75 
disease_progression 
H-positive risk:  814 771 123 1014 340 105 1086 361 146 55 118 67 
H-negative risk:  771 814 1086 1014 361 340 105 123 118 146 67 55 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 86 22 

clinical_engagement 
diagnosis 
demography 
70 new agents 
76 
disease_progression 
H-positive risk:  824 768 124 1012 341 103 1080 367 149 52 116 64 
H-negative risk:  768 824 1080 1012 367 341 103 124 116 149 64 52 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 87 23 

clinical_engagement 
diagnosis 
demography 
72 new agents 
77 
disease_progression 
H-positive risk:  820 771 124 1017 335 105 1070 376 150 54 114 64 
H-negative risk:  771 820 1070 1017 376 335 105 124 114 150 64 54 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 85 23 

clinical_engagement 
diagnosis 
demography 
62 new agents 
78 
disease_progression 
H-positive risk:  823 774 123 1019 331 106 1069 375 150 53 114 63 
H-negative risk:  774 823 1069 1019 375 331 106 123 114 150 63 53 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 82 23 

clinical_engagement 
diagnosis 
demography 
70 new agents 
79 
disease_progression 
H-positive risk:  826 777 124 1013 326 101 1073 378 152 53 113 64 
H-negative risk:  777 826 1073 1013 378 326 101 124 113 152 64 53 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 83 23 

clinical_engagement 
diagnosis 
demography 
68 new agents 
80 
disease_progression 
H-positive risk:  821 780 123 1014 322 100 1077 381 150 53 113 66 
H-negative risk:  780 821 1077 1014 381 322 100 123 113 150 66 53 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 82 22 

clinical_engagement 
diagnosis 
demography 
69 new agents 
81 
disease_progression 
H-positive risk:  821 777 121 1022 321 101 1081 381 148 49 115 63 
H-negative risk:  777 821 1081 1022 381 321 101 121 115 148 63 49 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 82 22 

clinical_engagement 
diagnosis 
demography 
66 new agents 
82 
disease_progression 
H-positive risk:  820 783 117 1020 322 102 1076 381 148 49 119 63 
H-negative risk:  783 820 1076 1020 381 322 102 117 119 148 63 49 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 81 22 

clinical_engagement 
diagnosis 
demography 
68 new agents 
83 
disease_progression 
H-positive risk:  818 785 119 1015 326 103 1079 377 149 48 118 63 
H-negative risk:  785 818 1079 1015 377 326 103 119 118 149 63 48 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 83 23 

clinical_engagement 
diagnosis 
demography 
80 new agents 
84 
disease_progression 
H-positive risk:  825 790 118 1017 325 102 1068 375 150 48 121 61 
H-negative risk:  790 825 1068 1017 375 325 102 118 121 150 61 48 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 79 24 

clinical_engagement 
diagnosis 
demography 
66 new agents 
85 
disease_progression 
H-positive risk:  771 747 108 1056 328 99 1120 376 156 49 129 61 
H-negative risk:  747 771 1120 1056 376 328 99 108 129 156 61 49 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 80 24 

clinical_engagement 
diagnosis 
demography 
112 new agents 
86 
disease_progression 
H-positive risk:  773 758 109 1047 330 97 1111 378 155 53 126 63 
H-negative risk:  758 773 1111 1047 378 330 97 109 126 155 63 53 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 80 23 

clinical_engagement 
diagnosis 
demography 
70 new agents 
87 
disease_progression 
H-positive risk:  776 766 108 1036 335 96 1104 386 156 53 124 60 
H-negative risk:  766 776 1104 1036 386 335 96 108 124 156 60 53 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 79 21 

clinical_engagement 
diagnosis 
demography 
58 new agents 
88 
disease_progression 
H-positive risk:  771 767 108 1030 335 96 1110 392 155 54 125 57 
H-negative risk:  767 771 1110 1030 392 335 96 108 125 155 57 54 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 77 21 

clinical_engagement 
diagnosis 
demography 
82 new agents 
89 
disease_progression 
H-positive risk:  772 771 107 1027 331 95 1116 390 155 53 126 57 
H-negative risk:  771 772 1116 1027 390 331 95 107 126 155 57 53 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 78 21 

clinical_engagement 
diagnosis 
demography 
85 new agents 
90 
disease_progression 
H-positive risk:  770 770 109 1025 327 98 1125 391 152 51 123 59 
H-negative risk:  770 770 1125 1025 391 327 98 109 123 152 59 51 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 75 21 

clinical_engagement 
diagnosis 
demography 
59 new agents 
91 
disease_progression 
H-positive risk:  768 768 109 1029 325 98 1128 392 147 52 125 59 
H-negative risk:  768 768 1128 1029 392 325 98 109 125 147 59 52 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 77 21 

clinical_engagement 
diagnosis 
demography 
61 new agents 
92 
disease_progression 
H-positive risk:  769 761 111 1037 324 96 1124 394 148 53 123 60 
H-negative risk:  761 769 1124 1037 394 324 96 111 123 148 60 53 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 81 22 

clinical_engagement 
diagnosis 
demography 
74 new agents 
93 
disease_progression 
H-positive risk:  776 768 110 1031 312 97 1121 401 150 54 123 57 
H-negative risk:  768 776 1121 1031 401 312 97 110 123 150 57 54 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 80 23 

clinical_engagement 
diagnosis 
demography 
75 new agents 
94 
disease_progression 
H-positive risk:  784 778 114 1030 314 95 1115 392 149 54 119 56 
H-negative risk:  778 784 1115 1030 392 314 95 114 119 149 56 54 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 80 20 

clinical_engagement 
diagnosis 
demography 
72 new agents 
95 
disease_progression 
H-positive risk:  774 783 111 1022 325 95 1118 393 149 52 119 59 
H-negative risk:  783 774 1118 1022 393 325 95 111 119 149 59 52 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 81 20 

clinical_engagement 
diagnosis 
demography 
75 new agents 
96 
disease_progression 
H-positive risk:  777 781 110 1009 326 96 1123 396 149 52 122 59 
H-negative risk:  781 777 1123 1009 396 326 96 110 122 149 59 52 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 80 18 

clinical_engagement 
diagnosis 
demography 
67 new agents 
97 
disease_progression 
H-positive risk:  731 744 109 1041 323 90 1180 391 155 51 125 60 
H-negative risk:  744 731 1180 1041 391 323 90 109 125 155 60 51 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 81 17 

clinical_engagement 
diagnosis 
demography 
102 new agents 
98 
disease_progression 
H-positive risk:  727 740 109 1040 333 89 1170 402 155 51 126 58 
H-negative risk:  740 727 1170 1040 402 333 89 109 126 155 58 51 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 82 18 

clinical_engagement 
diagnosis 
demography 
83 new agents 
99 
disease_progression 
H-positive risk:  721 738 111 1038 335 90 1177 394 152 54 132 58 
H-negative risk:  738 721 1177 1038 394 335 90 111 132 152 58 54 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 79 19 

clinical_engagement 
diagnosis 
demography 
68 new agents 
100 
disease_progression 
H-positive risk:  720 743 111 1030 338 92 1172 395 153 55 133 58 
H-negative risk:  743 720 1172 1030 395 338 92 111 133 153 58 55 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 79 18 

clinical_engagement 
diagnosis 
demography 
73 new agents 
101 
disease_progression 
H-positive risk:  717 749 113 1025 338 90 1178 395 155 51 132 57 
H-negative risk:  749 717 1178 1025 395 338 90 113 132 155 57 51 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 78 17 

clinical_engagement 
diagnosis 
demography 
70 new agents 
102 
disease_progression 
H-positive risk:  719 751 115 1028 335 90 1178 393 156 51 132 52 
H-negative risk:  751 719 1178 1028 393 335 90 115 132 156 52 51 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 78 16 

clinical_engagement 
diagnosis 
demography 
81 new agents 
103 
disease_progression 
H-positive risk:  720 750 115 1033 326 92 1178 392 158 53 133 50 
H-negative risk:  750 720 1178 1033 392 326 92 115 133 158 50 53 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 76 15 

clinical_engagement 
diagnosis 
demography 
54 new agents 
104 
disease_progression 
H-positive risk:  724 748 114 1037 328 92 1173 397 154 55 130 48 
H-negative risk:  748 724 1173 1037 397 328 92 114 130 154 48 55 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 76 16 

clinical_engagement 
diagnosis 
demography 
74 new agents 
105 
disease_progression 
H-positive risk:  725 736 112 1054 327 93 1169 396 153 59 129 47 
H-negative risk:  736 725 1169 1054 396 327 93 112 129 153 47 59 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 75 15 

clinical_engagement 
diagnosis 
demography 
80 new agents 
106 
disease_progression 
H-positive risk:  716 735 111 1062 330 93 1169 398 153 58 129 46 
H-negative risk:  735 716 1169 1062 398 330 93 111 129 153 46 58 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 76 15 

clinical_engagement 
diagnosis 
demography 
57 new agents 
107 
disease_progression 
H-positive risk:  715 739 113 1065 324 94 1168 394 153 60 129 46 
H-negative risk:  739 715 1168 1065 394 324 94 113 129 153 46 60 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 76 15 

clinical_engagement 
diagnosis 
demography 
64 new agents 
108 
disease_progression 
H-positive risk:  717 740 114 1066 330 94 1165 392 151 60 129 42 
H-negative risk:  740 717 1165 1066 392 330 94 114 129 151 42 60 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 71 15 

clinical_engagement 
diagnosis 
demography 
81 new agents 
109 
disease_progression 
H-positive risk:  684 691 107 1109 335 88 1203 383 159 59 137 45 
H-negative risk:  691 684 1203 1109 383 335 88 107 137 159 45 59 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 71 15 

clinical_engagement 
diagnosis 
demography 
86 new agents 
110 
disease_progression 
H-positive risk:  687 693 103 1099 343 88 1191 393 159 60 139 45 
H-negative risk:  693 687 1191 1099 393 343 88 103 139 159 45 60 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 73 15 

clinical_engagement 
diagnosis 
demography 
93 new agents 
111 
disease_progression 
H-positive risk:  693 690 103 1092 350 89 1189 392 158 60 140 44 
H-negative risk:  690 693 1189 1092 392 350 89 103 140 158 44 60 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 72 15 

clinical_engagement 
diagnosis 
demography 
70 new agents 
112 
disease_progression 
H-positive risk:  698 691 106 1098 342 85 1184 392 163 59 138 44 
H-negative risk:  691 698 1184 1098 392 342 85 106 138 163 44 59 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 72 13 

clinical_engagement 
diagnosis 
demography 
77 new agents 
113 
disease_progression 
H-positive risk:  699 684 106 1102 343 85 1179 396 164 60 137 45 
H-negative risk:  684 699 1179 1102 396 343 85 106 137 164 45 60 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 72 13 

clinical_engagement 
diagnosis 
demography 
77 new agents 
114 
disease_progression 
H-positive risk:  692 674 107 1117 344 84 1177 400 165 59 135 46 
H-negative risk:  674 692 1177 1117 400 344 84 107 135 165 46 59 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 72 13 

clinical_engagement 
diagnosis 
demography 
58 new agents 
115 
disease_progression 
H-positive risk:  690 675 107 1119 345 84 1173 397 169 60 135 46 
H-negative risk:  675 690 1173 1119 397 345 84 107 135 169 46 60 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 75 12 

clinical_engagement 
diagnosis 
demography 
60 new agents 
116 
disease_progression 
H-positive risk:  693 675 108 1114 351 84 1180 389 168 58 134 46 
H-negative risk:  675 693 1180 1114 389 351 84 108 134 168 46 58 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 74 13 

clinical_engagement 
diagnosis 
demography 
69 new agents 
117 
disease_progression 
H-positive risk:  703 671 110 1114 349 83 1177 387 167 61 134 44 
H-negative risk:  671 703 1177 1114 387 349 83 110 134 167 44 61 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 70 14 

clinical_engagement 
diagnosis 
demography 
70 new agents 
118 
disease_progression 
H-positive risk:  695 665 107 1122 352 83 1184 393 161 60 137 41 
H-negative risk:  665 695 1184 1122 393 352 83 107 137 161 41 60 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 70 14 

clinical_engagement 
diagnosis 
demography 
73 new agents 
119 
disease_progression 
H-positive risk:  697 658 106 1127 344 85 1187 394 158 64 136 44 
H-negative risk:  658 697 1187 1127 394 344 85 106 136 158 44 64 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 69 15 

clinical_engagement 
diagnosis 
demography 
53 new agents 
120 
disease_progression 
H-positive risk:  689 660 105 1131 345 85 1191 390 158 65 135 46 
H-negative risk:  660 689 1191 1131 390 345 85 105 135 158 46 65 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 72 17 

clinical_engagement 
diagnosis 
demography 
65 new agents 
121 
disease_progression 
H-positive risk:  652 629 100 1165 340 84 1235 388 162 65 134 46 
H-negative risk:  629 652 1235 1165 388 340 84 100 134 162 46 65 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 72 17 

clinical_engagement 
diagnosis 
demography 
89 new agents 
122 
disease_progression 
H-positive risk:  644 633 100 1159 347 85 1226 403 160 69 132 42 
H-negative risk:  633 644 1226 1159 403 347 85 100 132 160 42 69 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 71 16 

clinical_engagement 
diagnosis 
demography 
76 new agents 
123 
disease_progression 
H-positive risk:  644 639 100 1153 357 83 1223 399 162 68 129 43 
H-negative risk:  639 644 1223 1153 399 357 83 100 129 162 43 68 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 70 15 

clinical_engagement 
diagnosis 
demography 
76 new agents 
124 
disease_progression 
H-positive risk:  640 648 105 1147 350 84 1227 399 161 64 128 47 
H-negative risk:  648 640 1227 1147 399 350 84 105 128 161 47 64 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 71 14 

clinical_engagement 
diagnosis 
demography 
75 new agents 
125 
disease_progression 
H-positive risk:  637 642 102 1158 349 85 1239 390 155 64 133 46 
H-negative risk:  642 637 1239 1158 390 349 85 102 133 155 46 64 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 70 14 

clinical_engagement 
diagnosis 
demography 
78 new agents 
126 
disease_progression 
H-positive risk:  634 650 103 1156 348 89 1233 390 150 66 133 48 
H-negative risk:  650 634 1233 1156 390 348 89 103 133 150 48 66 
New BC onsets:  80
BC status:  4920 80 
BC subtype:  4920 68 12 

clinical_engagement 
diagnosis 
demography 
79 new agents 
127 
disease_progression 
H-positive risk:  644 652 101 1151 346 87 1233 384 150 66 135 51 
H-negative risk:  652 644 1233 1151 384 346 87 101 135 150 51 66 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 70 12 

clinical_engagement 
diagnosis 
demography 
72 new agents 
128 
disease_progression 
H-positive risk:  647 651 100 1161 341 89 1224 388 149 62 139 49 
H-negative risk:  651 647 1224 1161 388 341 89 100 139 149 49 62 
New BC onsets:  83
BC status:  4917 83 
BC subtype:  4917 71 12 

clinical_engagement 
diagnosis 
demography 
77 new agents 
129 
disease_progression 
H-positive risk:  639 656 100 1154 341 92 1226 388 149 63 142 50 
H-negative risk:  656 639 1226 1154 388 341 92 100 142 149 50 63 
New BC onsets:  79
BC status:  4921 79 
BC subtype:  4921 67 12 

clinical_engagement 
diagnosis 
demography 
65 new agents 
130 
disease_progression 
H-positive risk:  641 648 98 1159 340 94 1226 385 150 64 143 52 
H-negative risk:  648 641 1226 1159 385 340 94 98 143 150 52 64 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 70 12 

clinical_engagement 
diagnosis 
demography 
75 new agents 
131 
disease_progression 
H-positive risk:  635 653 97 1150 337 94 1227 394 153 64 145 51 
H-negative risk:  653 635 1227 1150 394 337 94 97 145 153 51 64 
New BC onsets:  81
BC status:  4919 81 
BC subtype:  4919 69 12 

clinical_engagement 
diagnosis 
demography 
69 new agents 
132 
disease_progression 
H-positive risk:  633 651 100 1156 335 95 1225 397 150 64 144 50 
H-negative risk:  651 633 1225 1156 397 335 95 100 144 150 50 64 
New BC onsets:  83
BC status:  4917 83 
BC subtype:  4917 68 15 

clinical_engagement 
diagnosis 
demography 
56 new agents 
133 
disease_progression 
H-positive risk:  632 648 100 1152 342 95 1229 394 151 63 146 48 
H-negative risk:  648 632 1229 1152 394 342 95 100 146 151 48 63 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 69 16 

clinical_engagement 
diagnosis 
demography 
88 new agents 
134 
disease_progression 
H-positive risk:  631 640 99 1142 354 93 1217 411 155 65 148 45 
H-negative risk:  640 631 1217 1142 411 354 93 99 148 155 45 65 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 70 16 

clinical_engagement 
diagnosis 
demography 
78 new agents 
135 
disease_progression 
H-positive risk:  632 635 97 1139 363 97 1209 408 159 63 152 46 
H-negative risk:  635 632 1209 1139 408 363 97 97 152 159 46 63 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 71 15 

clinical_engagement 
diagnosis 
demography 
74 new agents 
136 
disease_progression 
H-positive risk:  642 633 99 1129 357 95 1210 411 160 64 153 47 
H-negative risk:  633 642 1210 1129 411 357 95 99 153 160 47 64 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 73 15 

clinical_engagement 
diagnosis 
demography 
86 new agents 
137 
disease_progression 
H-positive risk:  649 636 97 1131 357 93 1202 409 160 63 159 44 
H-negative risk:  636 649 1202 1131 409 357 93 97 159 160 44 63 
New BC onsets:  83
BC status:  4917 83 
BC subtype:  4917 70 13 

clinical_engagement 
diagnosis 
demography 
83 new agents 
138 
disease_progression 
H-positive risk:  648 638 98 1127 354 95 1204 416 156 61 157 46 
H-negative risk:  638 648 1204 1127 416 354 95 98 157 156 46 61 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 69 15 

clinical_engagement 
diagnosis 
demography 
63 new agents 
139 
disease_progression 
H-positive risk:  644 637 98 1138 354 95 1202 418 151 60 156 47 
H-negative risk:  637 644 1202 1138 418 354 95 98 156 151 47 60 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 69 15 

clinical_engagement 
diagnosis 
demography 
62 new agents 
140 
disease_progression 
H-positive risk:  634 640 100 1132 359 98 1204 416 151 59 159 48 
H-negative risk:  640 634 1204 1132 416 359 98 100 159 151 48 59 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 72 15 

clinical_engagement 
diagnosis 
demography 
80 new agents 
141 
disease_progression 
H-positive risk:  631 644 100 1127 361 96 1215 413 149 59 158 47 
H-negative risk:  644 631 1215 1127 413 361 96 100 158 149 47 59 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 72 17 

clinical_engagement 
diagnosis 
demography 
85 new agents 
142 
disease_progression 
H-positive risk:  641 647 102 1125 363 96 1199 417 150 57 156 47 
H-negative risk:  647 641 1199 1125 417 363 96 102 156 150 47 57 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 70 19 

clinical_engagement 
diagnosis 
demography 
74 new agents 
143 
disease_progression 
H-positive risk:  639 641 102 1135 368 94 1197 417 151 54 156 46 
H-negative risk:  641 639 1197 1135 417 368 94 102 156 151 46 54 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 70 20 

clinical_engagement 
diagnosis 
demography 
78 new agents 
144 
disease_progression 
H-positive risk:  643 649 101 1126 367 95 1191 421 153 53 156 45 
H-negative risk:  649 643 1191 1126 421 367 95 101 156 153 45 53 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 70 20 

clinical_engagement 
diagnosis 
demography 
80 new agents 
145 
disease_progression 
H-positive risk:  644 657 100 1117 369 93 1189 417 153 57 160 44 
H-negative risk:  657 644 1189 1117 417 369 93 100 160 153 44 57 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 66 20 

clinical_engagement 
diagnosis 
demography 
83 new agents 
146 
disease_progression 
H-positive risk:  634 647 100 1113 379 94 1183 432 153 58 163 44 
H-negative risk:  647 634 1183 1113 432 379 94 100 163 153 44 58 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 65 21 

clinical_engagement 
diagnosis 
demography 
81 new agents 
147 
disease_progression 
H-positive risk:  622 655 100 1119 378 92 1180 440 148 57 166 43 
H-negative risk:  655 622 1180 1119 440 378 92 100 166 148 43 57 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 66 21 

clinical_engagement 
diagnosis 
demography 
62 new agents 
148 
disease_progression 
H-positive risk:  617 657 98 1123 381 94 1183 435 148 55 167 42 
H-negative risk:  657 617 1183 1123 435 381 94 98 167 148 42 55 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 68 21 

clinical_engagement 
diagnosis 
demography 
74 new agents 
149 
disease_progression 
H-positive risk:  618 661 101 1123 387 94 1174 428 149 58 162 45 
H-negative risk:  661 618 1174 1123 428 387 94 101 162 149 45 58 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 70 21 

clinical_engagement 
diagnosis 
demography 
86 new agents 
150 
disease_progression 
H-positive risk:  618 667 104 1116 389 91 1175 424 151 60 162 43 
H-negative risk:  667 618 1175 1116 424 389 91 104 162 151 43 60 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 66 20 

clinical_engagement 
diagnosis 
demography 
70 new agents 
151 
disease_progression 
H-positive risk:  615 664 101 1116 389 94 1173 429 150 61 161 47 
H-negative risk:  664 615 1173 1116 429 389 94 101 161 150 47 61 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 68 20 

clinical_engagement 
diagnosis 
demography 
79 new agents 
152 
disease_progression 
H-positive risk:  615 664 101 1119 385 93 1173 437 149 55 162 47 
H-negative risk:  664 615 1173 1119 437 385 93 101 162 149 47 55 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 69 21 

clinical_engagement 
diagnosis 
demography 
77 new agents 
153 
disease_progression 
H-positive risk:  621 662 101 1130 379 93 1171 425 152 56 164 46 
H-negative risk:  662 621 1171 1130 425 379 93 101 164 152 46 56 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 71 21 

clinical_engagement 
diagnosis 
demography 
85 new agents 
154 
disease_progression 
H-positive risk:  626 658 104 1128 375 98 1173 418 150 59 164 47 
H-negative risk:  658 626 1173 1128 418 375 98 104 164 150 47 59 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 71 21 

clinical_engagement 
diagnosis 
demography 
71 new agents 
155 
disease_progression 
H-positive risk:  629 648 104 1122 376 97 1182 422 151 60 164 45 
H-negative risk:  648 629 1182 1122 422 376 97 104 164 151 45 60 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 69 21 

clinical_engagement 
diagnosis 
demography 
72 new agents 
156 
disease_progression 
H-positive risk:  639 639 105 1134 377 94 1178 414 152 62 164 42 
H-negative risk:  639 639 1178 1134 414 377 94 105 164 152 42 62 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 69 21 

clinical_engagement 
diagnosis 
demography 
67 new agents 
157 
disease_progression 
H-positive risk:  642 640 107 1133 377 95 1180 412 152 60 162 40 
H-negative risk:  640 642 1180 1133 412 377 95 107 162 152 40 60 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 69 20 

clinical_engagement 
diagnosis 
demography 
101 new agents 
158 
disease_progression 
H-positive risk:  646 642 106 1115 382 98 1173 423 148 62 163 42 
H-negative risk:  642 646 1173 1115 423 382 98 106 163 148 42 62 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 69 19 

clinical_engagement 
diagnosis 
demography 
69 new agents 
159 
disease_progression 
H-positive risk:  645 641 105 1117 380 96 1170 426 145 65 163 47 
H-negative risk:  641 645 1170 1117 426 380 96 105 163 145 47 65 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 69 19 

clinical_engagement 
diagnosis 
demography 
83 new agents 
160 
disease_progression 
H-positive risk:  640 637 108 1129 387 95 1165 429 142 63 160 45 
H-negative risk:  637 640 1165 1129 429 387 95 108 160 142 45 63 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 69 19 

clinical_engagement 
diagnosis 
demography 
80 new agents 
161 
disease_progression 
H-positive risk:  641 636 106 1148 386 95 1163 422 139 61 161 42 
H-negative risk:  636 641 1163 1148 422 386 95 106 161 139 42 61 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 70 23 

clinical_engagement 
diagnosis 
demography 
79 new agents 
162 
disease_progression 
H-positive risk:  633 640 105 1152 380 97 1165 425 139 61 160 43 
H-negative risk:  640 633 1165 1152 425 380 97 105 160 139 43 61 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 69 24 

clinical_engagement 
diagnosis 
demography 
72 new agents 
163 
disease_progression 
H-positive risk:  632 645 106 1149 380 97 1171 417 139 61 162 41 
H-negative risk:  645 632 1171 1149 417 380 97 106 162 139 41 61 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 68 24 

clinical_engagement 
diagnosis 
demography 
63 new agents 
164 
disease_progression 
H-positive risk:  625 653 106 1153 378 100 1177 410 139 58 160 41 
H-negative risk:  653 625 1177 1153 410 378 100 106 160 139 41 58 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 69 24 

clinical_engagement 
diagnosis 
demography 
83 new agents 
165 
disease_progression 
H-positive risk:  623 663 104 1148 376 102 1182 410 134 59 160 39 
H-negative risk:  663 623 1182 1148 410 376 102 104 160 134 39 59 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 69 24 

clinical_engagement 
diagnosis 
demography 
69 new agents 
166 
disease_progression 
H-positive risk:  629 658 102 1144 382 105 1180 408 139 55 159 39 
H-negative risk:  658 629 1180 1144 408 382 105 102 159 139 39 55 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 73 24 

clinical_engagement 
diagnosis 
demography 
68 new agents 
167 
disease_progression 
H-positive risk:  629 663 100 1140 390 103 1169 411 138 55 162 40 
H-negative risk:  663 629 1169 1140 411 390 103 100 162 138 40 55 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 73 25 

clinical_engagement 
diagnosis 
demography 
95 new agents 
168 
disease_progression 
H-positive risk:  640 658 101 1149 386 104 1159 411 134 54 164 40 
H-negative risk:  658 640 1159 1149 411 386 104 101 164 134 40 54 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 72 25 

clinical_engagement 
diagnosis 
demography 
76 new agents 
169 
disease_progression 
H-positive risk:  648 658 98 1150 379 104 1157 414 129 56 162 45 
H-negative risk:  658 648 1157 1150 414 379 104 98 162 129 45 56 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 73 23 

clinical_engagement 
diagnosis 
demography 
79 new agents 
170 
disease_progression 
H-positive risk:  651 646 97 1150 382 103 1150 425 128 59 164 45 
H-negative risk:  646 651 1150 1150 425 382 103 97 164 128 45 59 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 76 21 

clinical_engagement 
diagnosis 
demography 
62 new agents 
171 
disease_progression 
H-positive risk:  653 647 95 1152 385 104 1142 427 128 57 166 44 
H-negative risk:  647 653 1142 1152 427 385 104 95 166 128 44 57 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 76 21 

clinical_engagement 
diagnosis 
demography 
74 new agents 
172 
disease_progression 
H-positive risk:  654 654 96 1144 386 106 1144 423 130 54 167 42 
H-negative risk:  654 654 1144 1144 423 386 106 96 167 130 42 54 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 74 21 

clinical_engagement 
diagnosis 
demography 
73 new agents 
173 
disease_progression 
H-positive risk:  651 658 100 1147 384 106 1134 428 133 51 167 41 
H-negative risk:  658 651 1134 1147 428 384 106 100 167 133 41 51 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 75 20 

clinical_engagement 
diagnosis 
demography 
88 new agents 
174 
disease_progression 
H-positive risk:  650 660 98 1140 386 104 1142 423 137 50 168 42 
H-negative risk:  660 650 1142 1140 423 386 104 98 168 137 42 50 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 73 21 

clinical_engagement 
diagnosis 
demography 
61 new agents 
175 
disease_progression 
H-positive risk:  645 652 97 1134 391 104 1147 431 137 50 168 44 
H-negative risk:  652 645 1147 1134 431 391 104 97 168 137 44 50 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 72 21 

clinical_engagement 
diagnosis 
demography 
78 new agents 
176 
disease_progression 
H-positive risk:  648 663 97 1128 387 101 1155 421 137 53 167 43 
H-negative risk:  663 648 1155 1128 421 387 101 97 167 137 43 53 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 71 20 

clinical_engagement 
diagnosis 
demography 
76 new agents 
177 
disease_progression 
H-positive risk:  649 668 96 1123 392 99 1157 418 137 52 165 44 
H-negative risk:  668 649 1157 1123 418 392 99 96 165 137 44 52 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 70 18 

clinical_engagement 
diagnosis 
demography 
86 new agents 
178 
disease_progression 
H-positive risk:  645 671 95 1119 400 98 1158 415 139 48 169 43 
H-negative risk:  671 645 1158 1119 415 400 98 95 169 139 43 48 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 68 18 

clinical_engagement 
diagnosis 
demography 
81 new agents 
179 
disease_progression 
H-positive risk:  658 670 94 1112 405 100 1158 414 133 47 164 45 
H-negative risk:  670 658 1158 1112 414 405 100 94 164 133 45 47 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 68 17 

clinical_engagement 
diagnosis 
demography 
76 new agents 
180 
disease_progression 
H-positive risk:  658 668 94 1123 403 99 1145 414 133 48 169 46 
H-negative risk:  668 658 1145 1123 414 403 99 94 169 133 46 48 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 67 17 

clinical_engagement 
diagnosis 
demography 
74 new agents 
181 
disease_progression 
H-positive risk:  664 666 96 1124 398 100 1144 409 134 49 170 46 
H-negative risk:  666 664 1144 1124 409 398 100 96 170 134 46 49 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 70 17 

clinical_engagement 
diagnosis 
demography 
87 new agents 
182 
disease_progression 
H-positive risk:  659 673 96 1113 412 99 1142 415 134 49 161 47 
H-negative risk:  673 659 1142 1113 415 412 99 96 161 134 47 49 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 71 17 

clinical_engagement 
diagnosis 
demography 
79 new agents 
183 
disease_progression 
H-positive risk:  665 672 96 1109 414 101 1140 416 132 46 162 47 
H-negative risk:  672 665 1140 1109 416 414 101 96 162 132 47 46 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 71 18 

clinical_engagement 
diagnosis 
demography 
71 new agents 
184 
disease_progression 
H-positive risk:  663 676 95 1109 412 100 1142 418 130 45 163 47 
H-negative risk:  676 663 1142 1109 418 412 100 95 163 130 47 45 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 74 21 

clinical_engagement 
diagnosis 
demography 
73 new agents 
185 
disease_progression 
H-positive risk:  665 685 97 1105 410 98 1135 422 129 43 164 47 
H-negative risk:  685 665 1135 1105 422 410 98 97 164 129 47 43 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 77 22 

clinical_engagement 
diagnosis 
demography 
78 new agents 
186 
disease_progression 
H-positive risk:  662 687 96 1113 408 98 1132 419 131 41 168 45 
H-negative risk:  687 662 1132 1113 419 408 98 96 168 131 45 41 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 76 22 

clinical_engagement 
diagnosis 
demography 
69 new agents 
187 
disease_progression 
H-positive risk:  664 685 97 1107 412 97 1130 422 132 42 169 43 
H-negative risk:  685 664 1130 1107 422 412 97 97 169 132 43 42 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 74 22 

clinical_engagement 
diagnosis 
demography 
66 new agents 
188 
disease_progression 
H-positive risk:  663 689 95 1103 419 100 1118 428 128 47 167 43 
H-negative risk:  689 663 1118 1103 428 419 100 95 167 128 43 47 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 79 22 

clinical_engagement 
diagnosis 
demography 
81 new agents 
189 
disease_progression 
H-positive risk:  661 696 97 1103 422 98 1115 425 130 43 169 41 
H-negative risk:  696 661 1115 1103 425 422 98 97 169 130 41 43 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 81 21 

clinical_engagement 
diagnosis 
demography 
65 new agents 
190 
disease_progression 
H-positive risk:  659 697 99 1100 418 94 1120 429 132 40 172 40 
H-negative risk:  697 659 1120 1100 429 418 94 99 172 132 40 40 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 80 21 

clinical_engagement 
diagnosis 
demography 
66 new agents 
191 
disease_progression 
H-positive risk:  660 690 100 1100 421 95 1119 426 131 42 171 45 
H-negative risk:  690 660 1119 1100 426 421 95 100 171 131 45 42 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 82 21 

clinical_engagement 
diagnosis 
demography 
72 new agents 
192 
disease_progression 
H-positive risk:  655 695 99 1100 418 95 1110 432 137 42 173 44 
H-negative risk:  695 655 1110 1100 432 418 95 99 173 137 44 42 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 80 22 

clinical_engagement 
diagnosis 
demography 
67 new agents 
193 
disease_progression 
H-positive risk:  652 693 99 1098 423 95 1116 432 137 44 166 45 
H-negative risk:  693 652 1116 1098 432 423 95 99 166 137 45 44 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 83 23 

clinical_engagement 
diagnosis 
demography 
95 new agents 
194 
disease_progression 
H-positive risk:  651 703 97 1093 427 93 1097 444 139 44 161 51 
H-negative risk:  703 651 1097 1093 444 427 93 97 161 139 51 44 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 85 23 

clinical_engagement 
diagnosis 
demography 
88 new agents 
195 
disease_progression 
H-positive risk:  660 702 96 1093 427 95 1086 443 138 45 165 50 
H-negative risk:  702 660 1086 1093 443 427 95 96 165 138 50 45 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 88 23 

clinical_engagement 
diagnosis 
demography 
69 new agents 
196 
disease_progression 
H-positive risk:  660 700 94 1097 422 95 1091 437 141 46 161 56 
H-negative risk:  700 660 1091 1097 437 422 95 94 161 141 56 46 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 88 23 

clinical_engagement 
diagnosis 
demography 
80 new agents 
197 
disease_progression 
H-positive risk:  655 702 94 1098 421 98 1098 438 140 47 157 52 
H-negative risk:  702 655 1098 1098 438 421 98 94 157 140 52 47 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 91 22 

clinical_engagement 
diagnosis 
demography 
71 new agents 
198 
disease_progression 
H-positive risk:  656 700 94 1100 419 95 1095 443 140 50 153 55 
H-negative risk:  700 656 1095 1100 443 419 95 94 153 140 55 50 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 89 23 

clinical_engagement 
diagnosis 
demography 
87 new agents 
199 
disease_progression 
H-positive risk:  658 706 94 1092 415 98 1092 447 140 51 150 57 
H-negative risk:  706 658 1092 1092 447 415 98 94 150 140 57 51 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 86 22 

clinical_engagement 
diagnosis 
demography 
70 new agents 
200 
disease_progression 
H-positive risk:  659 702 98 1091 416 98 1088 449 140 53 149 57 
H-negative risk:  702 659 1088 1091 449 416 98 98 149 140 57 53 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 92 21 

clinical_engagement 
diagnosis 
demography 
78 new agents 
201 
disease_progression 
H-positive risk:  660 701 98 1094 425 93 1089 450 139 52 145 54 
H-negative risk:  701 660 1089 1094 450 425 93 98 145 139 54 52 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 94 20 

clinical_engagement 
diagnosis 
demography 
76 new agents 
202 
disease_progression 
H-positive risk:  662 699 101 1090 419 90 1096 446 145 52 143 57 
H-negative risk:  699 662 1096 1090 446 419 90 101 143 145 57 52 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 92 21 

clinical_engagement 
diagnosis 
demography 
70 new agents 
203 
disease_progression 
H-positive risk:  653 698 98 1096 420 87 1096 454 143 54 144 57 
H-negative risk:  698 653 1096 1096 454 420 87 98 144 143 57 54 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 92 20 

clinical_engagement 
diagnosis 
demography 
72 new agents 
204 
disease_progression 
H-positive risk:  649 699 100 1096 417 87 1104 451 143 53 144 57 
H-negative risk:  699 649 1104 1096 451 417 87 100 144 143 57 53 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 94 19 

clinical_engagement 
diagnosis 
demography 
76 new agents 
205 
disease_progression 
H-positive risk:  653 699 100 1089 414 87 1111 454 143 53 141 56 
H-negative risk:  699 653 1111 1089 454 414 87 100 141 143 56 53 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 95 19 

clinical_engagement 
diagnosis 
demography 
101 new agents 
206 
disease_progression 
H-positive risk:  650 706 99 1091 407 88 1098 461 147 52 143 58 
H-negative risk:  706 650 1098 1091 461 407 88 99 143 147 58 52 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 96 19 

clinical_engagement 
diagnosis 
demography 
92 new agents 
207 
disease_progression 
H-positive risk:  647 718 102 1088 407 91 1095 455 144 54 140 59 
H-negative risk:  718 647 1095 1088 455 407 91 102 140 144 59 54 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 95 19 

clinical_engagement 
diagnosis 
demography 
83 new agents 
208 
disease_progression 
H-positive risk:  638 721 102 1090 406 94 1088 454 143 58 146 60 
H-negative risk:  721 638 1088 1090 454 406 94 102 146 143 60 58 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 95 19 

clinical_engagement 
diagnosis 
demography 
69 new agents 
209 
disease_progression 
H-positive risk:  636 719 101 1100 412 93 1084 450 143 57 144 61 
H-negative risk:  719 636 1084 1100 450 412 93 101 144 143 61 57 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 94 20 

clinical_engagement 
diagnosis 
demography 
71 new agents 
210 
disease_progression 
H-positive risk:  640 715 101 1110 408 93 1077 450 146 56 145 59 
H-negative risk:  715 640 1077 1110 450 408 93 101 145 146 59 56 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 92 20 

clinical_engagement 
diagnosis 
demography 
82 new agents 
211 
disease_progression 
H-positive risk:  651 717 103 1104 412 91 1069 445 148 55 143 62 
H-negative risk:  717 651 1069 1104 445 412 91 103 143 148 62 55 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 93 21 

clinical_engagement 
diagnosis 
demography 
77 new agents 
212 
disease_progression 
H-positive risk:  647 712 98 1109 412 87 1080 442 151 56 144 62 
H-negative risk:  712 647 1080 1109 442 412 87 98 144 151 62 56 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 95 20 

clinical_engagement 
diagnosis 
demography 
73 new agents 
213 
disease_progression 
H-positive risk:  642 714 99 1122 412 90 1073 439 148 55 144 62 
H-negative risk:  714 642 1073 1122 439 412 90 99 144 148 62 55 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 96 21 

clinical_engagement 
diagnosis 
demography 
71 new agents 
214 
disease_progression 
H-positive risk:  639 716 99 1107 415 89 1074 444 152 55 146 64 
H-negative risk:  716 639 1074 1107 444 415 89 99 146 152 64 55 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 91 21 

clinical_engagement 
diagnosis 
demography 
56 new agents 
215 
disease_progression 
H-positive risk:  634 708 101 1115 422 89 1076 440 151 54 143 67 
H-negative risk:  708 634 1076 1115 440 422 89 101 143 151 67 54 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 93 21 

clinical_engagement 
diagnosis 
demography 
67 new agents 
216 
disease_progression 
H-positive risk:  630 709 99 1123 416 93 1071 440 150 56 143 70 
H-negative risk:  709 630 1071 1123 440 416 93 99 143 150 70 56 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 94 22 

clinical_engagement 
diagnosis 
demography 
75 new agents 
217 
disease_progression 
H-positive risk:  634 707 98 1116 417 94 1066 453 147 55 141 72 
H-negative risk:  707 634 1066 1116 453 417 94 98 141 147 72 55 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 91 20 

clinical_engagement 
diagnosis 
demography 
84 new agents 
218 
disease_progression 
H-positive risk:  631 701 100 1115 415 93 1079 454 146 54 141 71 
H-negative risk:  701 631 1079 1115 454 415 93 100 141 146 71 54 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 94 20 

clinical_engagement 
diagnosis 
demography 
72 new agents 
219 
disease_progression 
H-positive risk:  634 702 97 1117 417 95 1073 456 143 53 140 73 
H-negative risk:  702 634 1073 1117 456 417 95 97 140 143 73 53 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 94 21 

clinical_engagement 
diagnosis 
demography 
85 new agents 
220 
disease_progression 
H-positive risk:  642 709 89 1112 408 96 1077 450 145 51 150 71 
H-negative risk:  709 642 1077 1112 450 408 96 89 150 145 71 51 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 94 21 

clinical_engagement 
diagnosis 
demography 
67 new agents 
221 
disease_progression 
H-positive risk:  635 708 92 1111 408 96 1084 452 142 52 149 71 
H-negative risk:  708 635 1084 1111 452 408 96 92 149 142 71 52 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 96 21 

clinical_engagement 
diagnosis 
demography 
63 new agents 
222 
disease_progression 
H-positive risk:  635 712 89 1106 415 96 1090 441 143 51 149 73 
H-negative risk:  712 635 1090 1106 441 415 96 89 149 143 73 51 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 93 22 

clinical_engagement 
diagnosis 
demography 
63 new agents 
223 
disease_progression 
H-positive risk:  631 707 86 1113 416 98 1096 435 145 51 150 72 
H-negative risk:  707 631 1096 1113 435 416 98 86 150 145 72 51 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 96 21 

clinical_engagement 
diagnosis 
demography 
72 new agents 
224 
disease_progression 
H-positive risk:  639 705 86 1122 417 93 1089 434 150 49 146 70 
H-negative risk:  705 639 1089 1122 434 417 93 86 146 150 70 49 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 99 21 

clinical_engagement 
diagnosis 
demography 
59 new agents 
225 
disease_progression 
H-positive risk:  636 705 86 1118 422 91 1095 431 150 48 146 72 
H-negative risk:  705 636 1095 1118 431 422 91 86 146 150 72 48 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 98 19 

clinical_engagement 
diagnosis 
demography 
72 new agents 
226 
disease_progression 
H-positive risk:  632 701 86 1118 424 91 1098 434 151 47 146 72 
H-negative risk:  701 632 1098 1118 434 424 91 86 146 151 72 47 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 98 20 

clinical_engagement 
diagnosis 
demography 
98 new agents 
227 
disease_progression 
H-positive risk:  642 714 90 1110 417 88 1090 432 151 48 148 70 
H-negative risk:  714 642 1090 1110 432 417 88 90 148 151 70 48 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 99 18 

clinical_engagement 
diagnosis 
demography 
54 new agents 
228 
disease_progression 
H-positive risk:  643 717 93 1106 422 86 1083 438 152 44 146 70 
H-negative risk:  717 643 1083 1106 438 422 86 93 146 152 70 44 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 101 20 

clinical_engagement 
diagnosis 
demography 
68 new agents 
229 
disease_progression 
H-positive risk:  649 712 91 1087 443 86 1072 445 153 48 144 70 
H-negative risk:  712 649 1072 1087 445 443 86 91 144 153 70 48 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 100 20 

clinical_engagement 
diagnosis 
demography 
92 new agents 
230 
disease_progression 
H-positive risk:  647 718 91 1086 443 84 1073 444 152 47 148 67 
H-negative risk:  718 647 1073 1086 444 443 84 91 148 152 67 47 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 97 21 

clinical_engagement 
diagnosis 
demography 
72 new agents 
231 
disease_progression 
H-positive risk:  648 720 94 1079 440 83 1062 458 153 49 147 67 
H-negative risk:  720 648 1062 1079 458 440 83 94 147 153 67 49 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 96 20 

clinical_engagement 
diagnosis 
demography 
76 new agents 
232 
disease_progression 
H-positive risk:  647 719 95 1079 441 83 1058 460 155 49 144 70 
H-negative risk:  719 647 1058 1079 460 441 83 95 144 155 70 49 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 96 22 

clinical_engagement 
diagnosis 
demography 
79 new agents 
233 
disease_progression 
H-positive risk:  646 721 92 1076 441 84 1055 464 155 52 144 70 
H-negative risk:  721 646 1055 1076 464 441 84 92 144 155 70 52 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 97 23 

clinical_engagement 
diagnosis 
demography 
79 new agents 
234 
disease_progression 
H-positive risk:  653 726 90 1076 438 84 1045 466 157 50 146 69 
H-negative risk:  726 653 1045 1076 466 438 84 90 146 157 69 50 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 98 24 

clinical_engagement 
diagnosis 
demography 
75 new agents 
235 
disease_progression 
H-positive risk:  661 724 92 1063 448 84 1043 470 159 46 142 68 
H-negative risk:  724 661 1043 1063 470 448 84 92 142 159 68 46 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 95 25 

clinical_engagement 
diagnosis 
demography 
89 new agents 
236 
disease_progression 
H-positive risk:  670 721 90 1064 451 84 1034 470 159 47 141 69 
H-negative risk:  721 670 1034 1064 470 451 84 90 141 159 69 47 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 96 23 

clinical_engagement 
diagnosis 
demography 
77 new agents 
237 
disease_progression 
H-positive risk:  671 725 91 1059 451 81 1031 469 161 48 142 71 
H-negative risk:  725 671 1031 1059 469 451 81 91 142 161 71 48 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 99 20 

clinical_engagement 
diagnosis 
demography 
78 new agents 
238 
disease_progression 
H-positive risk:  673 725 89 1063 451 82 1030 467 161 45 142 72 
H-negative risk:  725 673 1030 1063 467 451 82 89 142 161 72 45 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 99 22 

clinical_engagement 
diagnosis 
demography 
83 new agents 
239 
disease_progression 
H-positive risk:  679 724 94 1059 453 84 1018 468 162 45 143 71 
H-negative risk:  724 679 1018 1059 468 453 84 94 143 162 71 45 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 99 22 

clinical_engagement 
diagnosis 
demography 
94 new agents 
240 
disease_progression 
H-positive risk:  677 734 94 1053 459 83 1016 460 164 48 143 69 
H-negative risk:  734 677 1016 1053 460 459 83 94 143 164 69 48 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 100 22 

clinical_engagement 
diagnosis 
demography 
70 new agents 
241 
disease_progression 
H-positive risk:  667 731 92 1044 468 80 1020 473 163 50 140 72 
H-negative risk:  731 667 1020 1044 473 468 80 92 140 163 72 50 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 97 24 

clinical_engagement 
diagnosis 
demography 
91 new agents 
242 
disease_progression 
H-positive risk:  662 730 94 1052 460 80 1024 471 165 49 142 71 
H-negative risk:  730 662 1024 1052 471 460 80 94 142 165 71 49 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 98 25 

clinical_engagement 
diagnosis 
demography 
70 new agents 
243 
disease_progression 
H-positive risk:  659 727 95 1051 454 80 1030 474 166 51 141 72 
H-negative risk:  727 659 1030 1051 474 454 80 95 141 166 72 51 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 97 26 

clinical_engagement 
diagnosis 
demography 
87 new agents 
244 
disease_progression 
H-positive risk:  669 719 93 1062 452 80 1022 482 164 47 142 68 
H-negative risk:  719 669 1022 1062 482 452 80 93 142 164 68 47 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 98 25 

clinical_engagement 
diagnosis 
demography 
77 new agents 
245 
disease_progression 
H-positive risk:  670 719 93 1068 451 79 1027 475 163 49 139 67 
H-negative risk:  719 670 1027 1068 475 451 79 93 139 163 67 49 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 99 24 

clinical_engagement 
diagnosis 
demography 
74 new agents 
246 
disease_progression 
H-positive risk:  669 718 91 1075 441 81 1029 481 162 48 136 69 
H-negative risk:  718 669 1029 1075 481 441 81 91 136 162 69 48 
New BC onsets:  124
BC status:  4876 124 
BC subtype:  4876 100 24 

clinical_engagement 
diagnosis 
demography 
69 new agents 
247 
disease_progression 
H-positive risk:  662 718 91 1081 438 79 1035 475 162 48 140 71 
H-negative risk:  718 662 1035 1081 475 438 79 91 140 162 71 48 
New BC onsets:  129
BC status:  4871 129 
BC subtype:  4871 105 24 

clinical_engagement 
diagnosis 
demography 
89 new agents 
248 
disease_progression 
H-positive risk:  674 714 92 1080 437 79 1038 465 162 47 140 72 
H-negative risk:  714 674 1038 1080 465 437 79 92 140 162 72 47 
New BC onsets:  126
BC status:  4874 126 
BC subtype:  4874 101 25 

clinical_engagement 
diagnosis 
demography 
56 new agents 
249 
disease_progression 
H-positive risk:  675 709 91 1090 433 77 1035 466 162 49 142 71 
H-negative risk:  709 675 1035 1090 466 433 77 91 142 162 71 49 
New BC onsets:  125
BC status:  4875 125 
BC subtype:  4875 99 26 

clinical_engagement 
diagnosis 
demography 
73 new agents 
250 
disease_progression 
H-positive risk:  684 702 90 1084 427 77 1035 471 163 50 145 72 
H-negative risk:  702 684 1035 1084 471 427 77 90 145 163 72 50 
New BC onsets:  125
BC status:  4875 125 
BC subtype:  4875 98 27 

clinical_engagement 
diagnosis 
demography 
77 new agents 
251 
disease_progression 
H-positive risk:  680 700 92 1079 434 82 1043 467 164 46 142 71 
H-negative risk:  700 680 1043 1079 467 434 82 92 142 164 71 46 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 93 29 

clinical_engagement 
diagnosis 
demography 
66 new agents 
252 
disease_progression 
H-positive risk:  677 701 91 1080 438 80 1042 461 167 47 142 74 
H-negative risk:  701 677 1042 1080 461 438 80 91 142 167 74 47 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 90 29 

clinical_engagement 
diagnosis 
demography 
81 new agents 
253 
disease_progression 
H-positive risk:  670 704 91 1083 434 78 1057 451 172 44 144 72 
H-negative risk:  704 670 1057 1083 451 434 78 91 144 172 72 44 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 92 29 

clinical_engagement 
diagnosis 
demography 
86 new agents 
254 
disease_progression 
H-positive risk:  679 710 91 1075 434 77 1058 447 169 47 144 69 
H-negative risk:  710 679 1058 1075 447 434 77 91 144 169 69 47 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 91 30 

clinical_engagement 
diagnosis 
demography 
79 new agents 
255 
disease_progression 
H-positive risk:  675 710 92 1078 440 76 1063 441 163 50 145 67 
H-negative risk:  710 675 1063 1078 441 440 76 92 145 163 67 50 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 91 29 

clinical_engagement 
diagnosis 
demography 
84 new agents 
256 
disease_progression 
H-positive risk:  680 703 94 1081 439 71 1065 445 164 50 144 64 
H-negative risk:  703 680 1065 1081 445 439 71 94 144 164 64 50 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 90 30 

clinical_engagement 
diagnosis 
demography 
79 new agents 
257 
disease_progression 
H-positive risk:  675 701 94 1090 439 77 1067 440 161 46 146 64 
H-negative risk:  701 675 1067 1090 440 439 77 94 146 161 64 46 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 87 30 

clinical_engagement 
diagnosis 
demography 
85 new agents 
258 
disease_progression 
H-positive risk:  672 708 94 1090 435 80 1069 437 160 43 145 67 
H-negative risk:  708 672 1069 1090 437 435 80 94 145 160 67 43 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 85 29 

clinical_engagement 
diagnosis 
demography 
77 new agents 
259 
disease_progression 
H-positive risk:  677 710 94 1080 433 81 1068 439 161 44 146 67 
H-negative risk:  710 677 1068 1080 439 433 81 94 146 161 67 44 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 85 28 

clinical_engagement 
diagnosis 
demography 
73 new agents 
260 
disease_progression 
H-positive risk:  685 696 94 1082 425 79 1074 437 163 47 150 68 
H-negative risk:  696 685 1074 1082 437 425 79 94 150 163 68 47 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 82 30 

clinical_engagement 
diagnosis 
demography 
58 new agents 
261 
disease_progression 
H-positive risk:  688 691 92 1085 416 79 1075 441 166 46 151 70 
H-negative risk:  691 688 1075 1085 441 416 79 92 151 166 70 46 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 81 29 

clinical_engagement 
diagnosis 
demography 
84 new agents 
262 
disease_progression 
H-positive risk:  691 692 95 1079 416 79 1069 444 164 44 157 70 
H-negative risk:  692 691 1069 1079 444 416 79 95 157 164 70 44 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 77 28 

clinical_engagement 
diagnosis 
demography 
83 new agents 
263 
disease_progression 
H-positive risk:  698 690 95 1077 419 77 1064 443 164 45 156 72 
H-negative risk:  690 698 1064 1077 443 419 77 95 156 164 72 45 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 77 28 

clinical_engagement 
diagnosis 
demography 
68 new agents 
264 
disease_progression 
H-positive risk:  702 691 95 1070 429 81 1053 446 163 44 155 71 
H-negative risk:  691 702 1053 1070 446 429 81 95 155 163 71 44 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 76 28 

clinical_engagement 
diagnosis 
demography 
91 new agents 
265 
disease_progression 
H-positive risk:  704 682 95 1074 430 80 1061 436 165 45 155 73 
H-negative risk:  682 704 1061 1074 436 430 80 95 155 165 73 45 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 76 30 

clinical_engagement 
diagnosis 
demography 
83 new agents 
266 
disease_progression 
H-positive risk:  707 677 93 1077 427 83 1063 440 165 44 153 71 
H-negative risk:  677 707 1063 1077 440 427 83 93 153 165 71 44 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 74 30 

clinical_engagement 
diagnosis 
demography 
73 new agents 
267 
disease_progression 
H-positive risk:  701 675 94 1080 427 82 1068 439 166 45 148 75 
H-negative risk:  675 701 1068 1080 439 427 82 94 148 166 75 45 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 78 27 

clinical_engagement 
diagnosis 
demography 
100 new agents 
268 
disease_progression 
H-positive risk:  699 684 93 1095 427 80 1063 428 166 42 150 73 
H-negative risk:  684 699 1063 1095 428 427 80 93 150 166 73 42 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 80 27 

clinical_engagement 
diagnosis 
demography 
89 new agents 
269 
disease_progression 
H-positive risk:  706 690 93 1096 424 77 1055 424 174 40 150 71 
H-negative risk:  690 706 1055 1096 424 424 77 93 150 174 71 40 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 80 27 

clinical_engagement 
diagnosis 
demography 
68 new agents 
270 
disease_progression 
H-positive risk:  704 695 95 1090 422 80 1049 435 171 42 146 71 
H-negative risk:  695 704 1049 1090 435 422 80 95 146 171 71 42 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 81 27 

clinical_engagement 
diagnosis 
demography 
66 new agents 
271 
disease_progression 
H-positive risk:  695 701 95 1094 418 80 1054 436 172 41 148 66 
H-negative risk:  701 695 1054 1094 436 418 80 95 148 172 66 41 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 80 27 

clinical_engagement 
diagnosis 
demography 
75 new agents 
272 
disease_progression 
H-positive risk:  694 710 94 1082 417 81 1070 429 168 42 149 64 
H-negative risk:  710 694 1070 1082 429 417 81 94 149 168 64 42 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 81 27 

clinical_engagement 
diagnosis 
demography 
77 new agents 
273 
disease_progression 
H-positive risk:  704 712 94 1082 412 81 1071 421 167 42 150 64 
H-negative risk:  712 704 1071 1082 421 412 81 94 150 167 64 42 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 80 28 

clinical_engagement 
diagnosis 
demography 
80 new agents 
274 
disease_progression 
H-positive risk:  703 713 93 1089 414 78 1068 417 168 41 152 64 
H-negative risk:  713 703 1068 1089 417 414 78 93 152 168 64 41 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 81 30 

clinical_engagement 
diagnosis 
demography 
81 new agents 
275 
disease_progression 
H-positive risk:  699 716 98 1087 417 78 1062 422 166 42 151 62 
H-negative risk:  716 699 1062 1087 422 417 78 98 151 166 62 42 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 77 31 

clinical_engagement 
diagnosis 
demography 
73 new agents 
276 
disease_progression 
H-positive risk:  697 714 98 1088 407 81 1067 430 162 42 149 65 
H-negative risk:  714 697 1067 1088 430 407 81 98 149 162 65 42 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 80 31 

clinical_engagement 
diagnosis 
demography 
72 new agents 
277 
disease_progression 
H-positive risk:  696 707 96 1100 408 82 1062 428 162 45 149 65 
H-negative risk:  707 696 1062 1100 428 408 82 96 149 162 65 45 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 79 30 

clinical_engagement 
diagnosis 
demography 
73 new agents 
278 
disease_progression 
H-positive risk:  706 711 92 1090 410 83 1061 423 165 44 147 68 
H-negative risk:  711 706 1061 1090 423 410 83 92 147 165 68 44 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 76 30 

clinical_engagement 
diagnosis 
demography 
92 new agents 
279 
disease_progression 
H-positive risk:  714 708 93 1103 409 83 1054 419 160 46 145 66 
H-negative risk:  708 714 1054 1103 419 409 83 93 145 160 66 46 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 77 29 

clinical_engagement 
diagnosis 
demography 
68 new agents 
280 
disease_progression 
H-positive risk:  719 703 92 1102 398 83 1068 423 160 44 145 63 
H-negative risk:  703 719 1068 1102 423 398 83 92 145 160 63 44 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 75 29 

clinical_engagement 
diagnosis 
demography 
68 new agents 
281 
disease_progression 
H-positive risk:  714 702 93 1102 400 84 1074 419 158 46 145 63 
H-negative risk:  702 714 1074 1102 419 400 84 93 145 158 63 46 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 76 28 

clinical_engagement 
diagnosis 
demography 
80 new agents 
282 
disease_progression 
H-positive risk:  711 706 95 1101 401 83 1076 419 154 48 143 63 
H-negative risk:  706 711 1076 1101 419 401 83 95 143 154 63 48 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 76 28 

clinical_engagement 
diagnosis 
demography 
79 new agents 
283 
disease_progression 
H-positive risk:  708 701 94 1108 401 89 1066 431 154 45 145 58 
H-negative risk:  701 708 1066 1108 431 401 89 94 145 154 58 45 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 74 28 

clinical_engagement 
diagnosis 
demography 
61 new agents 
284 
disease_progression 
H-positive risk:  704 698 93 1109 402 88 1077 429 154 45 145 56 
H-negative risk:  698 704 1077 1109 429 402 88 93 145 154 56 45 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 75 30 

clinical_engagement 
diagnosis 
demography 
64 new agents 
285 
disease_progression 
H-positive risk:  698 697 90 1117 400 88 1078 428 157 46 144 57 
H-negative risk:  697 698 1078 1117 428 400 88 90 144 157 57 46 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 75 32 

clinical_engagement 
diagnosis 
demography 
80 new agents 
286 
disease_progression 
H-positive risk:  703 690 92 1126 406 87 1066 422 161 48 142 57 
H-negative risk:  690 703 1066 1126 422 406 87 92 142 161 57 48 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 75 30 

clinical_engagement 
diagnosis 
demography 
82 new agents 
287 
disease_progression 
H-positive risk:  703 692 90 1124 403 89 1069 417 160 49 146 58 
H-negative risk:  692 703 1069 1124 417 403 89 90 146 160 58 49 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 72 30 

clinical_engagement 
diagnosis 
demography 
79 new agents 
288 
disease_progression 
H-positive risk:  706 686 91 1131 406 91 1065 409 163 48 145 59 
H-negative risk:  686 706 1065 1131 409 406 91 91 145 163 59 48 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 72 29 

clinical_engagement 
diagnosis 
demography 
77 new agents 
289 
disease_progression 
H-positive risk:  701 692 92 1131 407 91 1071 403 164 45 144 59 
H-negative risk:  692 701 1071 1131 403 407 91 92 144 164 59 45 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 73 29 

clinical_engagement 
diagnosis 
demography 
86 new agents 
290 
disease_progression 
H-positive risk:  699 698 91 1131 405 93 1067 401 159 48 147 61 
H-negative risk:  698 699 1067 1131 401 405 93 91 147 159 61 48 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 73 28 

clinical_engagement 
diagnosis 
demography 
70 new agents 
291 
disease_progression 
H-positive risk:  700 690 90 1131 417 95 1064 392 162 50 146 63 
H-negative risk:  690 700 1064 1131 392 417 95 90 146 162 63 50 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 75 28 

clinical_engagement 
diagnosis 
demography 
80 new agents 
292 
disease_progression 
H-positive risk:  696 687 93 1130 416 96 1074 397 160 48 142 61 
H-negative risk:  687 696 1074 1130 397 416 96 93 142 160 61 48 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 75 27 

clinical_engagement 
diagnosis 
demography 
94 new agents 
293 
disease_progression 
H-positive risk:  697 691 95 1113 420 99 1080 393 162 49 141 60 
H-negative risk:  691 697 1080 1113 393 420 99 95 141 162 60 49 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 71 31 

clinical_engagement 
diagnosis 
demography 
80 new agents 
294 
disease_progression 
H-positive risk:  709 699 102 1104 410 99 1075 390 158 52 142 60 
H-negative risk:  699 709 1075 1104 390 410 99 102 142 158 60 52 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 69 33 

clinical_engagement 
diagnosis 
demography 
82 new agents 
295 
disease_progression 
H-positive risk:  709 688 103 1102 419 99 1075 388 162 51 143 61 
H-negative risk:  688 709 1075 1102 388 419 99 103 143 162 61 51 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 71 34 

clinical_engagement 
diagnosis 
demography 
70 new agents 
296 
disease_progression 
H-positive risk:  700 689 103 1098 422 98 1080 390 160 52 145 63 
H-negative risk:  689 700 1080 1098 390 422 98 103 145 160 63 52 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 72 35 

clinical_engagement 
diagnosis 
demography 
68 new agents 
297 
disease_progression 
H-positive risk:  697 695 102 1093 417 100 1092 387 158 54 145 60 
H-negative risk:  695 697 1092 1093 387 417 100 102 145 158 60 54 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 74 35 

clinical_engagement 
diagnosis 
demography 
82 new agents 
298 
disease_progression 
H-positive risk:  695 691 104 1112 407 100 1086 387 154 58 146 60 
H-negative risk:  691 695 1086 1112 387 407 100 104 146 154 60 58 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 70 34 

clinical_engagement 
diagnosis 
demography 
82 new agents 
299 
disease_progression 
H-positive risk:  694 687 107 1116 402 102 1091 384 154 60 142 61 
H-negative risk:  687 694 1091 1116 384 402 102 107 142 154 61 60 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 70 35 

clinical_engagement 
diagnosis 
demography 
81 new agents 
300 
disease_progression 
H-positive risk:  693 682 109 1122 397 102 1098 382 155 59 143 58 
H-negative risk:  682 693 1098 1122 382 397 102 109 143 155 58 59 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 75 34 

clinical_engagement 
diagnosis 
demography 
74 new agents 
301 
disease_progression 
H-positive risk:  693 680 114 1110 407 102 1096 377 158 60 143 60 
H-negative risk:  680 693 1096 1110 377 407 102 114 143 158 60 60 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 78 32 

clinical_engagement 
diagnosis 
demography 
72 new agents 
302 
disease_progression 
H-positive risk:  693 680 115 1116 408 100 1106 366 156 62 141 57 
H-negative risk:  680 693 1106 1116 366 408 100 115 141 156 57 62 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 73 33 

clinical_engagement 
diagnosis 
demography 
92 new agents 
303 
disease_progression 
H-positive risk:  698 682 115 1107 410 101 1098 373 152 68 138 58 
H-negative risk:  682 698 1098 1107 373 410 101 115 138 152 58 68 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 74 32 

clinical_engagement 
diagnosis 
demography 
84 new agents 
304 
disease_progression 
H-positive risk:  705 674 113 1110 414 101 1096 371 153 69 138 56 
H-negative risk:  674 705 1096 1110 371 414 101 113 138 153 56 69 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 75 32 

clinical_engagement 
diagnosis 
demography 
84 new agents 
305 
disease_progression 
H-positive risk:  708 679 115 1107 403 101 1096 370 156 69 136 60 
H-negative risk:  679 708 1096 1107 370 403 101 115 136 156 60 69 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 74 33 

clinical_engagement 
diagnosis 
demography 
69 new agents 
306 
disease_progression 
H-positive risk:  704 670 116 1111 403 101 1098 374 157 70 139 57 
H-negative risk:  670 704 1098 1111 374 403 101 116 139 157 57 70 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 72 33 

clinical_engagement 
diagnosis 
demography 
80 new agents 
307 
disease_progression 
H-positive risk:  700 671 116 1118 402 104 1097 366 155 71 143 57 
H-negative risk:  671 700 1097 1118 366 402 104 116 143 155 57 71 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 72 32 

clinical_engagement 
diagnosis 
demography 
80 new agents 
308 
disease_progression 
H-positive risk:  692 669 115 1124 395 100 1104 371 154 73 146 57 
H-negative risk:  669 692 1104 1124 371 395 100 115 146 154 57 73 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 71 31 

clinical_engagement 
diagnosis 
demography 
78 new agents 
309 
disease_progression 
H-positive risk:  697 661 115 1129 395 100 1104 369 153 74 146 57 
H-negative risk:  661 697 1104 1129 369 395 100 115 146 153 57 74 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 74 30 

clinical_engagement 
diagnosis 
demography 
70 new agents 
310 
disease_progression 
H-positive risk:  697 660 114 1126 397 99 1097 374 155 77 146 58 
H-negative risk:  660 697 1097 1126 374 397 99 114 146 155 58 77 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 76 30 

clinical_engagement 
diagnosis 
demography 
85 new agents 
311 
disease_progression 
H-positive risk:  713 668 107 1113 400 98 1089 375 155 75 148 59 
H-negative risk:  668 713 1089 1113 375 400 98 107 148 155 59 75 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 79 28 

clinical_engagement 
diagnosis 
demography 
67 new agents 
312 
disease_progression 
H-positive risk:  707 671 105 1103 407 97 1088 383 156 71 150 62 
H-negative risk:  671 707 1088 1103 383 407 97 105 150 156 62 71 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 80 27 

clinical_engagement 
diagnosis 
demography 
65 new agents 
313 
disease_progression 
H-positive risk:  710 671 107 1108 402 98 1079 387 155 71 151 61 
H-negative risk:  671 710 1079 1108 387 402 98 107 151 155 61 71 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 81 27 

clinical_engagement 
diagnosis 
demography 
79 new agents 
314 
disease_progression 
H-positive risk:  700 658 110 1114 403 97 1068 409 154 73 151 63 
H-negative risk:  658 700 1068 1114 409 403 97 110 151 154 63 73 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 80 28 

clinical_engagement 
diagnosis 
demography 
69 new agents 
315 
disease_progression 
H-positive risk:  703 657 109 1103 405 103 1069 414 153 71 150 63 
H-negative risk:  657 703 1069 1103 414 405 103 109 150 153 63 71 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 80 30 

clinical_engagement 
diagnosis 
demography 
75 new agents 
316 
disease_progression 
H-positive risk:  693 662 112 1111 404 106 1061 414 155 70 150 62 
H-negative risk:  662 693 1061 1111 414 404 106 112 150 155 62 70 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 83 29 

clinical_engagement 
diagnosis 
demography 
76 new agents 
317 
disease_progression 
H-positive risk:  693 667 113 1104 406 106 1059 420 154 68 150 60 
H-negative risk:  667 693 1059 1104 420 406 106 113 150 154 60 68 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 85 27 

clinical_engagement 
diagnosis 
demography 
91 new agents 
318 
disease_progression 
H-positive risk:  689 670 113 1098 402 107 1063 421 156 66 154 61 
H-negative risk:  670 689 1063 1098 421 402 107 113 154 156 61 66 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 87 28 

clinical_engagement 
diagnosis 
demography 
73 new agents 
319 
disease_progression 
H-positive risk:  687 669 114 1105 393 105 1065 424 155 68 153 62 
H-negative risk:  669 687 1065 1105 424 393 105 114 153 155 62 68 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 87 29 

clinical_engagement 
diagnosis 
demography 
92 new agents 
320 
disease_progression 
H-positive risk:  698 671 117 1107 392 107 1048 426 155 69 145 65 
H-negative risk:  671 698 1048 1107 426 392 107 117 145 155 65 69 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 90 28 

clinical_engagement 
diagnosis 
demography 
77 new agents 
321 
disease_progression 
H-positive risk:  697 668 119 1113 396 106 1047 424 155 67 144 64 
H-negative risk:  668 697 1047 1113 424 396 106 119 144 155 64 67 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 89 28 

clinical_engagement 
diagnosis 
demography 
78 new agents 
322 
disease_progression 
H-positive risk:  702 673 120 1110 396 108 1051 413 156 61 144 66 
H-negative risk:  673 702 1051 1110 413 396 108 120 144 156 66 61 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 88 29 

clinical_engagement 
diagnosis 
demography 
78 new agents 
323 
disease_progression 
H-positive risk:  696 676 116 1108 412 107 1050 403 158 60 150 64 
H-negative risk:  676 696 1050 1108 403 412 107 116 150 158 64 60 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 90 28 

clinical_engagement 
diagnosis 
demography 
89 new agents 
324 
disease_progression 
H-positive risk:  694 680 119 1109 409 106 1039 410 154 64 151 65 
H-negative risk:  680 694 1039 1109 410 409 106 119 151 154 65 64 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 89 28 

clinical_engagement 
diagnosis 
demography 
82 new agents 
325 
disease_progression 
H-positive risk:  700 686 121 1105 402 107 1043 405 153 62 152 64 
H-negative risk:  686 700 1043 1105 405 402 107 121 152 153 64 62 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 89 26 

clinical_engagement 
diagnosis 
demography 
76 new agents 
326 
disease_progression 
H-positive risk:  703 679 118 1110 400 105 1044 406 152 64 155 64 
H-negative risk:  679 703 1044 1110 406 400 105 118 155 152 64 64 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 93 27 

clinical_engagement 
diagnosis 
demography 
85 new agents 
327 
disease_progression 
H-positive risk:  701 681 117 1105 409 103 1040 408 154 63 158 61 
H-negative risk:  681 701 1040 1105 408 409 103 117 158 154 61 63 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 96 27 

clinical_engagement 
diagnosis 
demography 
79 new agents 
328 
disease_progression 
H-positive risk:  691 677 116 1114 414 105 1037 414 155 58 156 63 
H-negative risk:  677 691 1037 1114 414 414 105 116 156 155 63 58 
New BC onsets:  125
BC status:  4875 125 
BC subtype:  4875 100 25 

clinical_engagement 
diagnosis 
demography 
72 new agents 
329 
disease_progression 
H-positive risk:  689 667 119 1117 417 107 1040 415 154 57 154 64 
H-negative risk:  667 689 1040 1117 415 417 107 119 154 154 64 57 
New BC onsets:  126
BC status:  4874 126 
BC subtype:  4874 102 24 

clinical_engagement 
diagnosis 
demography 
68 new agents 
330 
disease_progression 
H-positive risk:  690 668 112 1118 417 107 1038 423 151 58 156 62 
H-negative risk:  668 690 1038 1118 423 417 107 112 156 151 62 58 
New BC onsets:  126
BC status:  4874 126 
BC subtype:  4874 100 26 

clinical_engagement 
diagnosis 
demography 
76 new agents 
331 
disease_progression 
H-positive risk:  686 661 114 1123 415 107 1044 425 150 59 154 62 
H-negative risk:  661 686 1044 1123 425 415 107 114 154 150 62 59 
New BC onsets:  125
BC status:  4875 125 
BC subtype:  4875 101 24 

clinical_engagement 
diagnosis 
demography 
73 new agents 
332 
disease_progression 
H-positive risk:  679 662 113 1115 422 109 1054 423 145 59 155 64 
H-negative risk:  662 679 1054 1115 423 422 109 113 155 145 64 59 
New BC onsets:  127
BC status:  4873 127 
BC subtype:  4873 103 24 

clinical_engagement 
diagnosis 
demography 
84 new agents 
333 
disease_progression 
H-positive risk:  681 667 111 1105 423 111 1054 429 143 59 153 64 
H-negative risk:  667 681 1054 1105 429 423 111 111 153 143 64 59 
New BC onsets:  130
BC status:  4870 130 
BC subtype:  4870 105 25 

clinical_engagement 
diagnosis 
demography 
86 new agents 
334 
disease_progression 
H-positive risk:  682 669 109 1100 423 110 1060 423 142 62 155 65 
H-negative risk:  669 682 1060 1100 423 423 110 109 155 142 65 62 
New BC onsets:  126
BC status:  4874 126 
BC subtype:  4874 100 26 

clinical_engagement 
diagnosis 
demography 
75 new agents 
335 
disease_progression 
H-positive risk:  673 675 111 1095 422 109 1058 432 144 60 157 64 
H-negative risk:  675 673 1058 1095 432 422 109 111 157 144 64 60 
New BC onsets:  131
BC status:  4869 131 
BC subtype:  4869 102 29 

clinical_engagement 
diagnosis 
demography 
88 new agents 
336 
disease_progression 
H-positive risk:  687 673 110 1097 415 112 1053 432 144 58 154 65 
H-negative risk:  673 687 1053 1097 432 415 112 110 154 144 65 58 
New BC onsets:  130
BC status:  4870 130 
BC subtype:  4870 103 27 

clinical_engagement 
diagnosis 
demography 
87 new agents 
337 
disease_progression 
H-positive risk:  689 680 113 1095 408 112 1057 430 141 56 151 68 
H-negative risk:  680 689 1057 1095 430 408 112 113 151 141 68 56 
New BC onsets:  128
BC status:  4872 128 
BC subtype:  4872 101 27 

clinical_engagement 
diagnosis 
demography 
82 new agents 
338 
disease_progression 
H-positive risk:  693 684 111 1082 411 111 1062 428 138 60 150 70 
H-negative risk:  684 693 1062 1082 428 411 111 111 150 138 70 60 
New BC onsets:  126
BC status:  4874 126 
BC subtype:  4874 101 25 

clinical_engagement 
diagnosis 
demography 
86 new agents 
339 
disease_progression 
H-positive risk:  693 680 113 1084 408 108 1075 420 142 61 147 69 
H-negative risk:  680 693 1075 1084 420 408 108 113 147 142 69 61 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 99 24 

clinical_engagement 
diagnosis 
demography 
86 new agents 
340 
disease_progression 
H-positive risk:  700 683 110 1088 408 106 1066 419 146 59 145 70 
H-negative risk:  683 700 1066 1088 419 408 106 110 145 146 70 59 
New BC onsets:  125
BC status:  4875 125 
BC subtype:  4875 101 24 

clinical_engagement 
diagnosis 
demography 
72 new agents 
341 
disease_progression 
H-positive risk:  700 683 108 1093 408 108 1067 412 148 59 146 68 
H-negative risk:  683 700 1067 1093 412 408 108 108 146 148 68 59 
New BC onsets:  127
BC status:  4873 127 
BC subtype:  4873 104 23 

clinical_engagement 
diagnosis 
demography 
88 new agents 
342 
disease_progression 
H-positive risk:  713 681 107 1092 403 110 1067 407 150 57 145 68 
H-negative risk:  681 713 1067 1092 407 403 110 107 145 150 68 57 
New BC onsets:  130
BC status:  4870 130 
BC subtype:  4870 108 22 

clinical_engagement 
diagnosis 
demography 
73 new agents 
343 
disease_progression 
H-positive risk:  719 684 106 1090 402 111 1067 403 154 53 145 66 
H-negative risk:  684 719 1067 1090 403 402 111 106 145 154 66 53 
New BC onsets:  128
BC status:  4872 128 
BC subtype:  4872 106 22 

clinical_engagement 
diagnosis 
demography 
67 new agents 
344 
disease_progression 
H-positive risk:  720 686 108 1093 406 110 1062 402 153 54 140 66 
H-negative risk:  686 720 1062 1093 402 406 110 108 140 153 66 54 
New BC onsets:  127
BC status:  4873 127 
BC subtype:  4873 105 22 

clinical_engagement 
diagnosis 
demography 
91 new agents 
345 
disease_progression 
H-positive risk:  717 671 107 1100 411 109 1070 402 151 55 140 67 
H-negative risk:  671 717 1070 1100 402 411 109 107 140 151 67 55 
New BC onsets:  127
BC status:  4873 127 
BC subtype:  4873 105 22 

clinical_engagement 
diagnosis 
demography 
63 new agents 
346 
disease_progression 
H-positive risk:  718 668 108 1108 415 106 1066 396 150 59 140 66 
H-negative risk:  668 718 1066 1108 396 415 106 108 140 150 66 59 
New BC onsets:  129
BC status:  4871 129 
BC subtype:  4871 107 22 

clinical_engagement 
diagnosis 
demography 
65 new agents 
347 
disease_progression 
H-positive risk:  720 661 106 1112 411 106 1063 406 153 57 139 66 
H-negative risk:  661 720 1063 1112 406 411 106 106 139 153 66 57 
New BC onsets:  127
BC status:  4873 127 
BC subtype:  4873 105 22 

clinical_engagement 
diagnosis 
demography 
88 new agents 
348 
disease_progression 
H-positive risk:  718 659 106 1117 412 109 1060 405 153 58 137 66 
H-negative risk:  659 718 1060 1117 405 412 109 106 137 153 66 58 
New BC onsets:  128
BC status:  4872 128 
BC subtype:  4872 106 22 

clinical_engagement 
diagnosis 
demography 
77 new agents 
349 
disease_progression 
H-positive risk:  718 656 104 1112 412 109 1076 396 152 60 140 65 
H-negative risk:  656 718 1076 1112 396 412 109 104 140 152 65 60 
New BC onsets:  127
BC status:  4873 127 
BC subtype:  4873 104 23 

clinical_engagement 
diagnosis 
demography 
75 new agents 
350 
disease_progression 
H-positive risk:  721 654 103 1109 411 109 1081 394 148 64 140 66 
H-negative risk:  654 721 1081 1109 394 411 109 103 140 148 66 64 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 100 23 

clinical_engagement 
diagnosis 
demography 
87 new agents 
351 
disease_progression 
H-positive risk:  719 657 106 1110 406 107 1085 391 151 61 142 65 
H-negative risk:  657 719 1085 1110 391 406 107 106 142 151 65 61 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 95 23 

clinical_engagement 
diagnosis 
demography 
86 new agents 
352 
disease_progression 
H-positive risk:  723 663 104 1112 399 107 1085 389 148 64 139 67 
H-negative risk:  663 723 1085 1112 389 399 107 104 139 148 67 64 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 94 23 

clinical_engagement 
diagnosis 
demography 
82 new agents 
353 
disease_progression 
H-positive risk:  728 661 101 1107 399 106 1085 394 145 66 146 62 
H-negative risk:  661 728 1085 1107 394 399 106 101 146 145 62 66 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 99 24 

clinical_engagement 
diagnosis 
demography 
70 new agents 
354 
disease_progression 
H-positive risk:  731 662 101 1107 397 105 1081 394 147 64 146 65 
H-negative risk:  662 731 1081 1107 394 397 105 101 146 147 65 64 
New BC onsets:  126
BC status:  4874 126 
BC subtype:  4874 104 22 

clinical_engagement 
diagnosis 
demography 
74 new agents 
355 
disease_progression 
H-positive risk:  729 660 104 1113 394 100 1081 388 155 64 146 66 
H-negative risk:  660 729 1081 1113 388 394 100 104 146 155 66 64 
New BC onsets:  124
BC status:  4876 124 
BC subtype:  4876 101 23 

clinical_engagement 
diagnosis 
demography 
64 new agents 
356 
disease_progression 
H-positive risk:  729 659 105 1111 400 101 1075 390 156 65 145 64 
H-negative risk:  659 729 1075 1111 390 400 101 105 145 156 64 65 
New BC onsets:  126
BC status:  4874 126 
BC subtype:  4874 103 23 

clinical_engagement 
diagnosis 
demography 
60 new agents 
357 
disease_progression 
H-positive risk:  719 659 104 1111 407 96 1080 391 158 68 144 63 
H-negative risk:  659 719 1080 1111 391 407 96 104 144 158 63 68 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 102 21 

clinical_engagement 
diagnosis 
demography 
66 new agents 
358 
disease_progression 
H-positive risk:  710 660 103 1109 409 98 1085 392 157 72 142 63 
H-negative risk:  660 710 1085 1109 392 409 98 103 142 157 63 72 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 100 21 

clinical_engagement 
diagnosis 
demography 
86 new agents 
359 
disease_progression 
H-positive risk:  716 659 107 1106 407 97 1085 390 158 71 143 61 
H-negative risk:  659 716 1085 1106 390 407 97 107 143 158 61 71 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 98 21 

clinical_engagement 
diagnosis 
demography 
71 new agents 
360 
disease_progression 
H-positive risk:  718 663 110 1095 406 98 1090 390 157 69 145 59 
H-negative risk:  663 718 1090 1095 390 406 98 110 145 157 59 69 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 102 21 

clinical_engagement 
diagnosis 
demography 
77 new agents 
Time difference of 18.04542 mins
This is task 26
date
